181 results on '"Xueying Mao"'
Search Results
2. Milk fat globule membrane supplementation protects against β-lactoglobulin-induced food allergy in mice via upregulation of regulatory T cells and enhancement of intestinal barrier in a microbiota-derived short-chain fatty acids manner
- Author
-
Han Gong, Tiange Li, Dong Liang, Jingxin Gao, Xiaohan Liu, and Xueying Mao
- Published
- 2023
- Full Text
- View/download PDF
3. Tissue resident memory T cells are enriched and dysfunctional in effusion of patients with malignant tumor
- Author
-
Xueying Mao, Yue Chen, Xiulian Lu, Shuiping Jin, Piao Jiang, Zhangfeng Deng, Xiaoyun Zhu, Qichun Cai, Changyou Wu, and Shuangpeng Kang
- Subjects
Oncology - Abstract
Purpose Most malignant effusion are secondary to metastases to the pleura or peritoneum and portend poor oncological outcomes. Malignant effusion have different tumor microenvironment from primary tumor, containing a variety of cytokines and immune cells and directly contacting with tumor cells. However, the characteristic of CD4+ T cells and CD8+ T cells in malignant effusion remains unclear. Methods Malignant effusion including peritoneal ascites and pleural fluid from thirty-five patients with malignant tumor were collected and compared with matched blood. A detailed characterization of CD4+ T cells and CD8+ T cells in malignant effusion were conducted using flow cytometry and multiple cytokines assay. Results The concentration of IL-6 in malignant effusion was significantly higher than in blood. A substantial portion of T cells in malignant effusion were CD69+ and/ or CD103+ Trm cells. Most CD4+T and CD8+T cells in malignant effusion were exhausted T cells which expressed lower levels of cytokines, cytotoxic molecules and markedly higher levels of inhibitory receptor PD-1 compared with in blood. Conclusion Our study is the first to identify the presence of Trm cells in malignant effusion and will lay the foundation for future research on anti-tumor immunity of Trm cells in malignant effusion.
- Published
- 2023
- Full Text
- View/download PDF
4. A Self-attention Graph Convolutional Network for Precision Multi-tumor Early Diagnostics with DNA Methylation Data
- Author
-
Xue Jiang, Zhiqi Li, Aamir Mehmood, Heng Wang, Qiankun Wang, Yanyi Chu, Xueying Mao, Jing Zhao, Mingming Jiang, Bowen Zhao, Guanning Lin, Edwin Wang, and Dongqing Wei
- Subjects
Health Informatics ,General Biochemistry, Genetics and Molecular Biology ,Computer Science Applications - Abstract
DNA methylation data-based precision tumor early diagnostics is emerging as state of the art technology, which could capture the signals of cancer occurrence 3∼5 years in advance and clinically more homogenous groups. At present, the sensitivity of early detection for many tumors is about 30%, which needs to be significantly improved. Nevertheless, based on the genome wide DNA methylation information, one could comprehensively characterize the entire molecular genetic landscape of the tumors and subtle differences among various tumors. With the accumulation of DNA methylation data, we need to develop high-performance methods that can model and consider more unbiased information. According to the above analysis, we have designed a self-attention graph convolutional network to automatically learn key methylation sites in a data-driven way for precision multi-tumor early diagnostics. Based on the selected methylation sites, we further trained a multi-class classification support vector machine. Large amount experiments have been conducted to investigate the performance of the computational pipeline. Experimental results demonstrated the effectiveness of the selected key methylation sites which are highly relevant for blood diagnosis.
- Published
- 2023
- Full Text
- View/download PDF
5. Gut microbiota mediates the alleviative effect of polar lipids-enriched milk fat globule membrane on obesity-induced glucose metabolism disorders in peripheral tissues in rat dams
- Author
-
Tiange Li, Qichen Yuan, Han Gong, Min Du, and Xueying Mao
- Subjects
Nutrition and Dietetics ,Endocrinology, Diabetes and Metabolism ,Medicine (miscellaneous) ,Lipid Droplets ,Diet, High-Fat ,Gastrointestinal Microbiome ,Rats ,Mice, Inbred C57BL ,Rats, Sprague-Dawley ,Mice ,Pregnancy ,Animals ,Insulin ,Female ,Obesity ,Glycolipids ,Insulin Resistance ,Glycoproteins - Abstract
Obesity during pregnancy and lactation not only increases the incidence of metabolic disorders and gestational diabetes in mothers, but also programs adiposity and related metabolic diseases in offspring. The aim of this study was to investigate the effects of milk polar lipids on gut microbiota and glucose metabolism in high-fat diet (HFD)-fed rat dams.Sprague Dawley (SD) female rats were fed a HFD for 8 weeks to induce obesity, followed by HFD with or without oral administration of polar lipids-enriched milk fat globule membrane (MFGM-PL) at 400 mg/kg BW during pregnancy and lactation. At the end of lactation, fresh fecal samples of dams were collected, the gut microbiota was assessed, and the insulin-signaling protein expression in peripheral tissues (adipose tissue, liver and skeletal muscle) were measured.MFGM-PL supplementation attenuated body weight gain, ameliorated serum lipid profiles and improved insulin sensitivity in obese dams at the end of lactation. 16 S rDNA sequencing revealed that MFGM-PL increased the community richness and diversity of gut microbiota. The composition of gut microbiota was also changed after MFGM-PL supplementation as shown by an increase in the ratio of Bacteroidetes/Firmicutes and the relative abundance of Akkermansia, as well as a decrease in the relative abundance of Ruminococcaceae. The functional prediction of microbial communities by PICRUSt analysis showed that there were 7 KEGG pathways related to carbohydrate metabolism changed after MFGM-PL supplementation to HFD dams, including glycolysis/gluconeogenesis and insulin signaling pathway. Furthermore, MFGM-PL improved insulin signaling in the peripheral tissues including liver, adipose tissue and skeletal muscle.MFGM-PL supplementation during pregnancy and lactation improves the glucose metabolism disorders in HFD-induced obese dams, which may be linked to the regulation of gut microbiota induced by MFGM-PL.
- Published
- 2022
- Full Text
- View/download PDF
6. Bovine α-lactalbumin-derived peptides attenuate TNF-α-induced insulin resistance and inflammation in 3T3-L1 adipocytes through inhibiting JNK and NF-κB signaling
- Author
-
Jing Gao, Kairui Guo, Min Du, and Xueying Mao
- Subjects
Inflammation ,inorganic chemicals ,MAP Kinase Kinase 4 ,Tumor Necrosis Factor-alpha ,macromolecular substances ,General Medicine ,environment and public health ,Mice ,enzymes and coenzymes (carbohydrates) ,3T3-L1 Cells ,Lactalbumin ,Animals ,Humans ,bacteria ,Cattle ,Caco-2 Cells ,Insulin Resistance ,Peptides ,Proto-Oncogene Proteins c-akt ,Signal Transduction ,Food Science - Abstract
Bioactive peptides in bovine α-lactalbumin were isolated and identified, and the effects and mechanisms of peptide KILDK on insulin resistance in 3T3-L1 adipocytes were investigated. Mature 3T3-L1 adipocytes were stimulated with TNF-α to induce insulin resistance. Bovine α-lactalbumin hydrolysates (α-LAH) were subjected to stimulated gastrointestinal digestion and Caco-2 absorption, and GD-α-LAH and CA-α-LAH were obtained. Our results demonstrated that α-LAH, GD-α-LAH, and CA-α-LAH increased glucose uptake, enhanced Akt phosphorylation (Ser473), and decreased IRS-1 phosphorylation (Ser307) in insulin resistant 3T3-L1 adipocytes. Gel filtration chromatography and liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI MS/MS) were used to separate and identify bioactive peptides. The identified peptide KILDK attenuated insulin resistance in 3T3-L1 adipocytes, which was attributed to the suppression of JNK phosphorylation (Thr183/Tyr185). Moreover, KILDK downregulated pro-inflammatory genes through blocking NF-κB signaling. Our findings suggested that bovine α-LAH might be a potential ingredient against insulin resistance.
- Published
- 2022
- Full Text
- View/download PDF
7. Supplementary materials and methods from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
- Author
-
Yong-Jie Lu, Jonathan Shamash, Daniel Berney, Amar Sabri Ahmad, R. Tim D. Oliver, Yuqin Wang, Elzbieta Stankiewicz, John Hines, Greg Shaw, Pui Ying Chan, Tianyu Guo, Xueying Mao, and Lei Xu
- Abstract
Additional clinical information of samples, details of antibodies used in immunofluorescence and probes in FISH.
- Published
- 2023
- Full Text
- View/download PDF
8. Data from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
- Author
-
Yong-Jie Lu, Jonathan Shamash, Daniel Berney, Amar Sabri Ahmad, R. Tim D. Oliver, Yuqin Wang, Elzbieta Stankiewicz, John Hines, Greg Shaw, Pui Ying Chan, Tianyu Guo, Xueying Mao, and Lei Xu
- Abstract
Purpose: To develop an approach for the investigation of different subtypes of circulating tumor cells (CTC) and other cells to evaluate their potential prognostic value of prostate cancer.Experimental Design: Malignancy of CTCs undergoing epithelial-to-mesenchymal transition (EMT) was confirmed by repeated FISH. Subgroups of CTCs in 81 patients with prostate cancer (43 castration resistant and 38 untreated localized) were correlated to disease aggressiveness parameters. AUC analysis was applied to compare the performance for metastasis prediction between serum PSA level alone and a combined risk score using both PSA and EMTing CTC count. Circulating megakaryocytes and cancer patient survival association was performed using Cox model.Results: The majority of vimentin (VIM)+/CD45− cells were malignant, with genomic alterations in several genomic regions. The number of cytokeratin (CK)−/VIM+/CD45− CTCs correlated with disease burden, tumor aggressiveness, and poorer survival. Meanwhile, CK+/VIM+/CD45− CTCs were associated with metastases better than other subtypes of CTCs in these limited samples. Combination of PSA level and the number of CK+/VIM+/CD45− CTCs enhanced the prediction of cancer metastases [AUC, 0.921; 95% confidence interval (CI), 0.858–0.985]. The number of circulating megakaryocytes was potentially associated with good patient survival in advanced prostate cancer (HR, 0.849; 95% CI, 0.628–1.146, per cell increase), and the difference between the number of mesenchymal CTCs and megakaryocytes strongly correlated to poor survival (HR, 10.17; 95% CI, 2.164–47.789, if score ≥2.0).Conclusions: This CTC analysis approach and the potential association of megakaryocytes with cancer prognosis may greatly enhance our ability to investigate the cancer metastasis process and to predict/monitor cancer progression. Clin Cancer Res; 23(17); 5112–22. ©2017 AACR.
- Published
- 2023
- Full Text
- View/download PDF
9. Table S1-S7 from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
- Author
-
Yong-Jie Lu, Jonathan Shamash, Daniel Berney, Amar Sabri Ahmad, R. Tim D. Oliver, Yuqin Wang, Elzbieta Stankiewicz, John Hines, Greg Shaw, Pui Ying Chan, Tianyu Guo, Xueying Mao, and Lei Xu
- Abstract
Supplementary Table 1-7. Table S1 Clinical characteristics and CTC/BigNeg cell count for all patients; Table S2 Summary of CTC FISH results in 12 prostate cancer patients and leukocyte signals from controls and patients; Table S3 Proportion of detected genetic changes in sub-populations of cells; Table S4 Clinical features of CTC-score positive and negative patients; Table S5 The number of subtype CTCs in different clinical feature groups; Table S6 ROC curves to predict metastases by CTC counts and PSA level; Table S7 The comparison of sensitivity and specificity to predict metastasis using PSA and CRS.
- Published
- 2023
- Full Text
- View/download PDF
10. Figure S1-S3 from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
- Author
-
Yong-Jie Lu, Jonathan Shamash, Daniel Berney, Amar Sabri Ahmad, R. Tim D. Oliver, Yuqin Wang, Elzbieta Stankiewicz, John Hines, Greg Shaw, Pui Ying Chan, Tianyu Guo, Xueying Mao, and Lei Xu
- Abstract
Supplementary Figure 1-3. Fig. S1 Representative five rounds of FISH images in a PC3 cell; Fig. S2 Box plots of CRS and BigNeg cell count; Fig. S3 Kaplan-Meier survival analysis by sub-populations of CTCs.
- Published
- 2023
- Full Text
- View/download PDF
11. Supplementary Figures 1-3, Tables 1-2 from Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells
- Author
-
Yong-Jie Lu, Daniel M. Berney, R. Tim D. Oliver, Sakunthala C. Kudahetti, Elzbieta Stankiewicz, Xueying Mao, Lara K. Boyd, and Nuria Coll Bastus
- Abstract
Supplementary Figures 1-3, Tables 1-2 from Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells
- Published
- 2023
- Full Text
- View/download PDF
12. Supplementary Table 1 from Downregulation of RBMS3 Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma
- Author
-
Xin-Yuan Guan, Li Fu, Ying-Hui Zhu, Yanru Qin, Xueying Mao, Haibo Liu, Ting-ting Zeng, Chang-jun Nie, Leilei Chen, and Yan Li
- Abstract
PDF file (55K)
- Published
- 2023
- Full Text
- View/download PDF
13. Data from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
- Author
-
Yong-Jie Lu, Bryan D. Young, Daniel M. Berney, Nick R. Lemoine, R. Tim D. Oliver, Manu Gupta, Luis Beltran, Liyan Xue, Elzbieta Stankiewicz, Sakunthala C. Kudahetti, Tracy Chaplin, Dongmei Lin, Guoping Ren, Lara K. Boyd, Yongwei Yu, and Xueying Mao
- Abstract
Prostate cancer is significantly more common in Western men than in Asian men, but the basis for this difference remains unknown. Because genomic studies of Asian prostate cancer are very limited, we used a genome-wide approach to reveal the genomic alterations in Chinese prostate cancers. We found a significant reduction in the frequency of certain somatic genomic changes that are commonly found in Western prostate cancers, including the 21q22.2-22.3 deletion, which involves the TMPRSS2:ERG fusion gene, and 10q deletion, which causes PTEN inactivation. Array results were confirmed by PCR-based molecular copy-number counting in selected samples. The different frequencies of these genomic changes were further evaluated by fluorescent in situ hybridization and immunohistochemistry analyses of tissue microarray samples. These alterations might be key genetic changes underlying the regional/ethnic difference in clinical incidence and might be induced by specific environmental and/or genetic risk factors that Western men are exposed to. Our findings suggest that tumors arise in Western and Chinese populations by alternative pathogenetic mechanisms. Cancer Res; 70(13); 5207–12. ©2010 AACR.
- Published
- 2023
- Full Text
- View/download PDF
14. Data from Downregulation of RBMS3 Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma
- Author
-
Xin-Yuan Guan, Li Fu, Ying-Hui Zhu, Yanru Qin, Xueying Mao, Haibo Liu, Ting-ting Zeng, Chang-jun Nie, Leilei Chen, and Yan Li
- Abstract
Deletions on chromosome 3p occur often in many solid tumors, including esophageal squamous cell carcinoma (ESCC), suggesting the existence at this location of one or more tumor suppressor genes (TSG). In this study, we characterized RBMS3 gene encoding an RNA-binding protein as a candidate TSG located at 3p24. Downregulation of RBMS3 mRNA and protein levels was documented in approximately 50% of the primary ESCCs examined. Clinical association studies determined that RBMS3 downregulation was associated with poor clinical outcomes. RBMS3 expression effectively suppressed the tumorigenicity of ESCC cells in vitro and in vivo, including by inhibition of cell growth rate, foci formation, soft agar colony formation, and tumor formation in nude mice. Molecular analyses revealed that RBMS3 downregulated c-Myc and CDK4, leading to subsequent inhibition of Rb phosphorylation. Together, our findings suggest a tumor suppression function for the human RBMS3 gene in ESCC, acting through c-Myc downregulation, with genetic loss of this gene in ESCC contributing to poor outcomes in this deadly disease. Cancer Res; 71(19); 6106–15. ©2011 AACR.
- Published
- 2023
- Full Text
- View/download PDF
15. Data from Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells
- Author
-
Yong-Jie Lu, Daniel M. Berney, R. Tim D. Oliver, Sakunthala C. Kudahetti, Elzbieta Stankiewicz, Xueying Mao, Lara K. Boyd, and Nuria Coll Bastus
- Abstract
Fusion genes play important roles in tumorigenesis. The identification of the high-frequency TMPRSS2 fusion with ERG and other ETS family genes in prostate cancer highlights the importance of fusion genes in solid tumor development and progression. However, the mechanisms leading to these fusions are unclear. We investigated whether androgen, through stimulating its receptor, could promote spatial genome reorganization and contribute to the generation of the TMPRSS2:ERG fusion. We show that treatment with androgen can induce the TMPRSS2:ERG fusion in both malignant and nonmalignant prostate epithelial cells. Although the fusion could be detected in malignant cells following 24-hour treatment, prolonged exposure to androgen was required to detect the fusion transcript in nonmalignant cells. We associated the fusion incidence with genetic factors, including androgen-induced gene proximity, androgen receptor exon1 CAG repeat length and expression of the PIWIL1 gene. This study demonstrates that fusions can be induced prior to malignant transformation and generation of the fusion is associated with both gene proximity and loss of the ability to prevent double-strand breaks. Cancer Res; 70(23); 9544–8. ©2010 AACR.
- Published
- 2023
- Full Text
- View/download PDF
16. Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
- Author
-
Yong-Jie Lu, Bryan D. Young, Daniel M. Berney, Nick R. Lemoine, R. Tim D. Oliver, Manu Gupta, Luis Beltran, Liyan Xue, Elzbieta Stankiewicz, Sakunthala C. Kudahetti, Tracy Chaplin, Dongmei Lin, Guoping Ren, Lara K. Boyd, Yongwei Yu, and Xueying Mao
- Abstract
Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
- Published
- 2023
- Full Text
- View/download PDF
17. Machine learning of flow cytometry data reveals the delayed innate immune responses correlate with the severity of COVID-19
- Author
-
Jing Zhu, Tunan Chen, Xueying Mao, Yitian Fang, Heqi Sun, Dong-Qing Wei, and Guangfu Ji
- Subjects
Immunology ,Immunology and Allergy - Abstract
IntroductionThe COVID-19 pandemic has posed a major burden on healthcare and economic systems across the globe for over 3 years. Even though vaccines are available, the pathogenesis is still unclear. Multiple studies have indicated heterogeneity of immune responses to SARS-CoV-2, and potentially distinct patient immune types that might be related to disease features. However, those conclusions are mainly inferred by comparing the differences of pathological features between moderate and severe patients, some immunological features may be subjectively overlooked.MethodsIn this study, the relevance scores(RS), reflecting which features play a more critical role in the decision-making process, between immunological features and the COVID-19 severity are objectively calculated through neural network, where the input features include the immune cell counts and the activation marker concentrations of particular cell, and these quantified characteristic data are robustly generated by processing flow cytometry data sets containing the peripheral blood information of COVID-19 patients through PhenoGraph algorithm.ResultsSpecifically, the RS between immune cell counts and COVID-19 severity with time indicated that the innate immune responses in severe patients are delayed at the early stage, and the continuous decrease of classical monocytes in peripherial blood is significantly associated with the severity of disease. The RS between activation marker concentrations and COVID-19 severity suggested that the down-regulation of IFN-γ in classical monocytes, Treg, CD8 T cells, and the not down-regulation of IL_17a in classical monocytes, Tregs are highly correlated with the occurrence of severe disease. Finally, a concise dynamic model of immune responses in COVID-19 patients was generalized.DiscussionThese results suggest that the delayed innate immune responses in the early stage, and the abnormal expression of IL-17a and IFN-γ in classical monocytes, Tregs, and CD8 T cells are primarily responsible for the severity of COVID-19.
- Published
- 2023
- Full Text
- View/download PDF
18. The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
- Author
-
Caitlin R. Davies, Tianyu Guo, Edwina Burke, Elzbieta Stankiewicz, Lei Xu, Xueying Mao, Glenda Scandura, Prabhakar Rajan, Karen Tipples, Constantine Alifrangis, Akhila Ganeshi Wimalasingham, Myria Galazi, Shanthini Crusz, Thomas Powles, Alistair Grey, Tim Oliver, Sakunthala Kudahetti, Greg Shaw, Daniel Berney, Jonathan Shamash, and Yong-Jie Lu
- Subjects
Cancer Research ,Oncology - Abstract
BackgroundDocetaxel improves overall survival (OS) in castration-resistant prostate cancer (PCa) (CRPC) and metastatic hormone-sensitive PCa (mHSPC). However, not all patients respond due to inherent and/or acquired resistance. There remains an unmet clinical need for a robust predictive test to stratify patients for treatment. Liquid biopsy of circulating tumour cell (CTCs) is minimally invasive, can provide real-time information of the heterogeneous tumour and therefore may be a potentially ideal docetaxel response prediction biomarker.ObjectiveIn this study we investigate the potential of using CTCs and their gene expression to predict post-docetaxel tumour response, OS and progression free survival (PFS).MethodsPeripheral blood was sampled from 18 mCRPC and 43 mHSPC patients, pre-docetaxel treatment, for CTC investigation. CTCs were isolated using the epitope independent Parsortix® system and gene expression was determined by multiplex RT-qPCR. We evaluated CTC measurements for post-docetaxel outcome prediction using receiver operating characteristics and Kaplan Meier analysis.ResultsDetection of CTCs pre-docetaxel was associated with poor patient outcome post-docetaxel treatment. Combining total-CTC number with PSA and ALP predicted lack of partial response (PR) with an AUC of 0.90, p= 0.037 in mCRPC. A significantly shorter median OS was seen in mCRPC patients with positive CTC-score (12.80 vs. 37.33 months, HR= 5.08, p= 0.0005), ≥3 total-CTCs/7.5mL (12.80 vs. 37.33 months, HR= 3.84, p= 0.0053), ≥1 epithelial-CTCs/7.5mL (14.30 vs. 37.33 months, HR= 3.89, p= 0.0041) or epithelial to mesenchymal transitioning (EMTing)-CTCs/7.5mL (11.32 vs. 32.37 months, HR= 6.73, p= 0.0001). Significantly shorter PFS was observed in patients with ≥2 epithelial-CTCs/7.5mL (7.52 vs. 18.83 months, HR= 3.93, p= 0.0058). mHSPC patients with ≥5 CTCs/7.5mL had significantly shorter median OS (24.57 vs undefined months, HR= 4.14, p= 0.0097). In mHSPC patients, expression of KLK2, KLK4, ADAMTS1, ZEB1 and SNAI1 was significantly associated with shorter OS and/or PFS. Importantly, combining CTC measurements with clinical biomarkers increased sensitivity and specificity for prediction of patient outcome.ConclusionWhile it is clear that CTC numbers and gene expression were prognostic for PCa post-docetaxel treatment, and CTC subtype analysis may have additional value, their potential predictive value for docetaxel chemotherapy response needs to be further investigated in large patient cohorts.
- Published
- 2023
- Full Text
- View/download PDF
19. Physicochemical properties of fluid milk with different heat treatments and HS-GC-IMS identification of volatile organic compounds
- Author
-
Jiale Zhao, Boran Zhou, Pengjie Wang, Fazheng Ren, and Xueying Mao
- Subjects
Applied Microbiology and Biotechnology ,Food Science - Published
- 2023
- Full Text
- View/download PDF
20. Preparation and identification of anti-breast cancer cells peptides released from yak milk casein
- Author
-
Haofeng, Gu, Lei, Liang, Ziwei, Zhu, and Xueying, Mao
- Subjects
Nutrition and Dietetics ,Endocrinology, Diabetes and Metabolism ,Food Science - Abstract
Yak milk casein (YMC) is the main protein in the yak milk. Peptides released from Yak milk casein (YMC) have multiple bioactivities, including anti-inflammation and immune-regulation, suggesting that these peptides might be able to inhibit cancer theoretically. However, the anti-cancer peptides from YMC have only been sparsely studied. Breast carcinoma is the most common carcinoma in women worldwide. Thus, the paper herein was to identify yak milk casein (YMC)-derived anti-breast cancer peptides via gel filtration, reversed phase high-performance liquid chromatography (RP-HPLC) and liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI MS/MS) for the first time. The inhibitory effects of the hydrolysates on the cell viabilities, cell cycles and apoptosis of breast cancer cells were evaluated with a cck8 kit and a flow cytometry. The result showed that YMC hydrolysates (YMCH) obtained by united hydrolyzation with trypsin (3 h) and alkaline protease (3 h) displayed the highest cell viability inhibition rate for MCF7 (20.74 ± 1.39%) and MDA-MB-231 (26.73 ± 2.87%) cells. Three peptides were identified in the RP-HPLC subfraction F3-4, and a nonapeptide (TPVVVPPFL) showed the most potent inhibitory effects on both cancer cells and displayed good gastrointestinal stability. TPVVVPPFL could induce G2-M cell cycle arrest in MCF7 cells and S cell arrest in MDA-MB-231 cells and induce apoptosis in both cancer cells. Moreover, in silico analysis indicated that the peptide had non-toxic and no inhibitory roles on P4502D6-enzyme. Together, this study shows that YMC is a good source of anti-breast cancer cells peptides.
- Published
- 2022
- Full Text
- View/download PDF
21. Milk fat globule membrane supplementation to obese rats during pregnancy and lactation promotes neurodevelopment in offspring via modulating gut microbiota
- Author
-
Qichen Yuan, Han Gong, Min Du, Tiange Li, and Xueying Mao
- Subjects
Nutrition and Dietetics ,Endocrinology, Diabetes and Metabolism ,Food Science - Abstract
Pre-pregnancy obesity and high-fat diet (HFD) during pregnancy and lactation are associated with neurodevelopmental delay in offspring. This study aimed to investigate whether milk fat globule membrane (MFGM) supplementation in obese dams could promote neurodevelopment in offspring. Obese female rats induced by HFD were supplemented with MFGM during pregnancy and lactation. Maternal HFD exposure significantly delayed the maturation of neurological reflexes and inhibited neurogenesis in offspring, which were significantly recovered by maternal MFGM supplementation. Gut microbiota analysis revealed that MFGM supplementation modulated the diversity and composition of gut microbiota in offspring. The abundance of pro-inflammatory bacteria such as Escherichia shigella and Enterococcus were down-regulated, and the abundance of bacteria with anti-inflammatory and anti-obesity functions, such as Akkermansia and Lactobacillus were up-regulated. Furthermore, MFGM alleviated neuroinflammation by decreasing the levels of lipopolysaccharides (LPS) and pro-inflammatory cytokines in the circulation and brain, as well as inhibiting the activation of microglia. Spearman’s correlation analysis suggested that there existed a correlation between gut microbiota and inflammation-related indexes. In conclusion, maternal MFGM supplementation promotes neurodevelopment partly via modulating gut microbiota in offspring.
- Published
- 2022
- Full Text
- View/download PDF
22. In vivo immunomodulatory alleviating effects of animal milk oligosaccharides on murine NEC: A study
- Author
-
Junrui Wu, Ruixue Ding, Shuyi Qi, Shuang Zhang, Liang Zhao, Guanghui Xiao, Yajie Cai, Hanchen Wang, Xueying Mao, and Rina Wu
- Subjects
Biochemistry ,Food Science - Published
- 2023
- Full Text
- View/download PDF
23. Metabolism, absorption, and anti-cancer effects of sulforaphane: an update
- Author
-
Hao-Feng Gu, Xueying Mao, and Min Du
- Subjects
030309 nutrition & dietetics ,Brassica ,Industrial and Manufacturing Engineering ,03 medical and health sciences ,chemistry.chemical_compound ,0404 agricultural biotechnology ,Isothiocyanates ,Cancer stem cell ,Neoplasms ,medicine ,Humans ,Epigenetics ,Mercapturic acid ,0303 health sciences ,Autophagy ,Cancer ,Lipid metabolism ,04 agricultural and veterinary sciences ,General Medicine ,medicine.disease ,040401 food science ,chemistry ,Sulfoxides ,Isothiocyanate ,Cancer research ,Food Science ,Sulforaphane - Abstract
Cancer is one of the most devastating diseases, and recently, a variety of natural compounds with preventive effects on cancer developments have been reported. Sulforaphane (SFN) is a potent anti-cancer isothiocyanate originating from Brassica oleracea (broccoli). SFN, mainly metabolized via mercapturic acid pathway, has high bioavailability and absorption. The present reviews mainly discussed the metabolism and absorption of SFN and newly discovered mechanistic understanding recent years for SFN's anti-cancer effects including promoting autophagy, inducing epigenetic modifications, suppressing glycolysis and fat metabolism. Moreover, its inhibitory effects on cancer stem cells and synergetic effects with other anti-cancer agents are also reviewed along with the clinical trials in this realm.
- Published
- 2021
- Full Text
- View/download PDF
24. Limited hydrolysis as a strategy to improve the non-covalent interaction of epigallocatechin-3-gallate (EGCG) with whey protein isolate near the isoelectric point
- Author
-
Jiale Zhao, Weimin Lin, Jingxin Gao, Han Gong, and Xueying Mao
- Subjects
Whey Proteins ,Protein Hydrolysates ,Hydrolysis ,Tryptophan ,Isoelectric Point ,Catechin ,Food Science - Abstract
This study was aimed to investigate the interaction mechanisms and structural changes of whey protein isolate (WPI) and whey protein isolate hydrolysates (WPIHs) with epigallocatechin-3-gallate (EGCG) near the isoelectric point through multiple spectroscopic techniques and field emission scanning electron microscopy. Fluorescence spectra results indicated that limited hydrolysis endowed WPIHs with higher affinity for the EGCG but the increased degree of hydrolysis led to an opposite result. Thermodynamic analysis revealed that EGCG bound WPI primarily through hydrogen bonds and van der waals forces, while the hydrophobic force was the main driving force in the interaction of EGCG with WPIHs. Synchronous fluorescence and three-dimensional spectra confirmed that EGCG induced conformational alterations of WPI and WPIHs, which was further supported by Ultraviolet-Visible spectra. Raman spectra indicated that binding to EGCG resulted in changes in the microenvironment of tryptophan residues, CH bending vibration and the secondary structure arrangements of WPI and WPIHs. Furthermore, compared with a sheet-like structure of WPI-EGCG complexes, the morphology of WPIHs with limited hydrolysis presented an uneven blocky structure after complexing with EGCG. Our findings might be helpful to better understand the interactions of milk protein hydrolysates-EGCG and suggest the potential application of the formed complexes as bioactive ingredients in food industry.
- Published
- 2022
25. Milk fat globule membrane supplementation to obese rats during pregnancy and lactation promotes neurodevelopment in offspring
- Author
-
Qichen, Yuan, Han, Gong, Min, Du, Tiange, Li, and Xueying, Mao
- Abstract
Pre-pregnancy obesity and high-fat diet (HFD) during pregnancy and lactation are associated with neurodevelopmental delay in offspring. This study aimed to investigate whether milk fat globule membrane (MFGM) supplementation in obese dams could promote neurodevelopment in offspring. Obese female rats induced by HFD were supplemented with MFGM during pregnancy and lactation. Maternal HFD exposure significantly delayed the maturation of neurological reflexes and inhibited neurogenesis in offspring, which were significantly recovered by maternal MFGM supplementation. Gut microbiota analysis revealed that MFGM supplementation modulated the diversity and composition of gut microbiota in offspring. The abundance of pro-inflammatory bacteria such as
- Published
- 2022
26. Identification of novel peptides from goat milk casein that ameliorate high-glucose-induced insulin resistance in HepG2 cells
- Author
-
K.R. Guo, Jing Gao, H. Gong, Q.W. Luo, Xueying Mao, Fazheng Ren, and Y. Wang
- Subjects
G6PC ,Hydrolysate ,03 medical and health sciences ,chemistry.chemical_compound ,Insulin resistance ,PCK1 ,Casein ,Genetics ,medicine ,Animals ,Humans ,Chromatography, High Pressure Liquid ,030304 developmental biology ,0303 health sciences ,Glycogen ,Goats ,Gluconeogenesis ,0402 animal and dairy science ,Caseins ,Hep G2 Cells ,04 agricultural and veterinary sciences ,medicine.disease ,040201 dairy & animal science ,Glucose ,Milk ,chemistry ,Biochemistry ,Glycogenesis ,Animal Science and Zoology ,Insulin Resistance ,Peptides ,Intracellular ,Chromatography, Liquid ,Food Science - Abstract
In this study, we investigated the effect of goat milk casein hydrolysates on glucose consumption rate, intracellular glycogen concentration, and mRNA expression of gluconeogenesis-related genes, including phosphoenolpyruvate carboxykinase 1 (PCK1) and glucose-6-phosphatase catalytic subunit (G6PC), in insulin-resistant HepG2 cells. From the obtained hydrolysates, we also purified and characterized novel peptides that ameliorated high-glucose-induced insulin resistance in HepG2 cells. The 3-h hydrolysate caused the highest glucose consumption rate in insulin-resistant HepG2 cells. It also showed positive effects on promoting intracellular glycogenesis and reducing mRNA expression of PCK1 and G6PC. We separated the obtained hydrolysates into 3 fractions (F1, F2, and F3) by gel filtration chromatography; we further purified F1 using reversed-phase HPLC and identified peptides using liquid chromatography-tandem mass spectrometry. The bioactive peptides identified were SDIPNPIGSE (αS1-casein, f195-204), NPWDQVKR (αS2-casein, f123-130), SLSSSEESITH (β-casein, f30-40), and QEPVLGPVRGPFP (β-casein, f207-219). Our findings indicated that specific bioactive peptides from goat milk casein hydrolysates ameliorated insulin resistance in HepG2 cells that had been treated with high glucose. This is a first step toward determining whether goat milk casein hydrolysates can be used as food ingredients to ameliorate insulin resistance.
- Published
- 2020
- Full Text
- View/download PDF
27. Chitosan oligosaccharide attenuates hepatic steatosis in HepG2 cells via the activation of AMP‐activated protein kinase
- Author
-
Tiange Li, Han Gong, Biyuan Zhan, and Xueying Mao
- Subjects
Pharmacology ,Chitosan ,Non-alcoholic Fatty Liver Disease ,Fatty Acids ,Biophysics ,Humans ,Oligosaccharides ,Hep G2 Cells ,Cell Biology ,AMP-Activated Protein Kinases ,Lipids ,Food Science - Abstract
Chitosan oligosaccharides (COSs), oligomers of decomposed chitosan possess many biological functions including immunomodulatory, antitumor, and antiinflammation. The aim of this study was to investigate the protective effects of COS against free fatty acid (FFA)-induced cellular hepatic steatosis and underlying mechanisms in HepG2 cells. Results showed that COS significantly reduced the lipid contents and elevated the activities of antioxidant enzymes including total-superoxide dismutase, glutathione peroxidase, and catalase in FFA-stimulated HepG2 cells. COS phosphorylated the acetyl-CoA carboxylase and reduced both mRNA and protein levels of lipogenesis markers including fatty acid synthase and sterol regulatory element-binding protein 1c. COS also significantly increased the expression levels of fatty acid oxidation-related factors including carnitine palmitoyltransferase 1A, acyl-coenzyme A oxidase 1, and peroxisome proliferators-activated receptor α. Besides, COS markedly phosphorylated AMP-activated protein kinase (AMPK). The inhibition of lipogenesis and the enhancement of fatty acid oxidation induced by COS were all blocked by AMPK antagonist (compound C), showing that the attenuation of hepatic steatosis by COS was dependent on AMPK activation. In conclusion, COS attenuated hepatic steatosis via suppressing lipid synthesis and enhancing fatty acid oxidation. AMPK was also involved in the alleviation of hepatic steatosis by COS. These results indicated that COS might be used as a potential ingredient to ameliorate nonalcoholic fatty liver disease. PRACTICAL APPLICATIONS: Nonalcoholic fatty liver disease (NAFLD) has been regarded as pathological fat deposition in the liver, which includes a range of pathologies, from steatosis to steatohepatitis, fibrosis, and cellular carcinoma. Our findings demonstrated that Chitosan oligosaccharides (COS) attenuated steatosis via improving lipid metabolism. COS suppressed lipogenesis and also enhanced fatty acid oxidation. Besides, the underlying molecular mechanism whereby COS elicited these beneficial effects has also been proved to be through the modulation of upstream protein kinase, AMP-activated protein kinase. This study provides new knowledge to support that COS might be used as a food supplement for the prevention of NAFLD.
- Published
- 2022
- Full Text
- View/download PDF
28. Yogurt Enriched with Inulin Ameliorated Reproductive Functions and Regulated Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice
- Author
-
Tiange Li, Yue Zhang, Jiajia Song, Lijun Chen, Min Du, and Xueying Mao
- Subjects
Synbiotics ,Article ,Bile Acids and Salts ,Mice ,Adjuvants, Immunologic ,Estrus ,Animals ,bile acid ,TX341-641 ,Nutrition and Dietetics ,gut microbiota ,inulin ,Nutrition. Foods and food supply ,Interleukins ,Body Weight ,Ovary ,synbiotic yogurt ,food and beverages ,Akkermansia ,Dehydroepiandrosterone ,polycystic ovary syndrome ,Luteinizing Hormone ,Yogurt ,Gastrointestinal Microbiome ,Mice, Inbred C57BL ,Lactobacillus ,Female ,Bifidobacterium ,Follicle Stimulating Hormone ,Food Science - Abstract
The effects of synbiotic yogurt supplemented with inulin on the pathological manifestations and gut microbiota–bile acid axis were investigated using a dehydroepiandrosterone (DHEA)-induced polycystic ovary syndrome (PCOS) mice model. Female C57BL/6J mice were injected subcutaneously with DHEA at a dose of 6 mg/100 g BW for 20 days to establish a PCOS mouse model. Then, the PCOS mice were treated with yogurt containing inulin (6% w/w) at 15 mL/kg BW for 24 days. Results showed that supplementation of synbiotic yogurt enriched with inulin to PCOS mice decreased the body weight gain, improved estrus cycles and ovary morphology, and reduced the levels of luteinizing hormone while increasing the levels of follicle-stimulating hormone and interleukin-22 in serum. At the genus level, synbiotic yogurt increased the relative abundance of Lactobacillus, Bifidobacterium, and Akkermansia. PICRUSt analysis indicated that KEGG pathways including bile acid biosynthesis were changed after inulin-enriched synbiotic yogurt supplementation. Synbiotic yogurt enriched with inulin also modulated the bile acid profiles. In conclusion, inulin-enriched synbiotic yogurt alleviated reproductive dysfunction and modulated gut microbiota and bile acid profiles in PCOS mice.
- Published
- 2022
- Full Text
- View/download PDF
29. Effects of high hydrostatic pressure treatment on the antigenicity, structural and digestive properties of whey protein
- Author
-
Hui Jiang, Zhiyi Zhang, Yongtao Wang, Jingxin Gao, Qichen Yuan, and Xueying Mao
- Subjects
Food Science - Published
- 2023
- Full Text
- View/download PDF
30. Conditioned medium from the bone marrow mesenchymal stem cells modulates immune response via signal transduction and activator of transcription 6 signaling pathway in an allergic rhinitis mouse model
- Author
-
Wentao Zou, Pei Zou, Jiaxiong Zhang, Xiaojing Cai, Xueying Mao, and Guangpeng Liu
- Subjects
Pulmonary and Respiratory Medicine ,Inflammation ,Mice, Inbred BALB C ,Ovalbumin ,Immunology ,Anti-Inflammatory Agents ,Immunity ,Mesenchymal Stem Cells ,General Medicine ,Immunoglobulin E ,Rhinitis, Allergic ,Disease Models, Animal ,Mice ,Culture Media, Conditioned ,Immunology and Allergy ,Animals ,Signal Transduction - Abstract
Background: Allergic rhinitis (AR) is a common immune disease of the nasal mucosa characterized with immunoglobulin E (IgE)-mediated allergic inflammation after exposure to allergens in susceptible population. Previous reports have demonstrated that the bone marrow mesenchymal stem cells (BMSCs) could reduce allergic inflammation. However, there is little knowledge about whether the culture supernatant of BMSCs (conditioned medium, CM) has similar anti- inflammatory potential in treating AR. Objective: The study aimed to evaluate the immunoregulatory effects of conditioned medium derived from BMSCs (BMSC-CM) on allergic inflammation in an AR mouse model. Material and Methods: The AR murine model was induced by repeated sensitization and challenges with ovalbumin (OVA). Subsequently the allergic symptoms of AR mice, cytokine levels, the histopathological features of the nasal mucosa and T helper 1 (Th1) : T helper 2 (Th2) cells ratio were evaluated. Results: Treatment with BMSC-CM was found as effective as BMSCs in reducing allergic symptoms and inhibiting eosinophilic infiltration in the nasal mucosa. After BMSC-CM or BMSCs administration, the OVA-specific IgE and interleukin 4 levels in serum decreased and interferon gamma level increased compared with AR mice treated with uncultured fresh medium. Flow cytometry analysis revealed a decrease in Th1:Th2 cells ratio after OVA-sensitization and the ratio was reversed by BMSC-CM and BMSCs treatments. Furthermore, the data revealed that BMSC-CM suppressed the production of signal transduction and activator of transcription 6 (STAT6) at messenger RNA and protein levels in the nasal mucosa. Conclusion: BMSC-CM could ameliorate allergic inflammation and regulate the balance of Th cells, and the underlying mechanism was closely related to STAT6 signaling pathway. The immunoregulatory effects of BMSCs could be achieved through paracrine function, and nasal dripping of BMSC-CM might be a novel approach for the treatment of AR.
- Published
- 2021
31. Flavor formation in frying process of green onion (Allium fistulosum L.) deep-fried oil
- Author
-
Ning Zhang, Yuyu Zhang, Baoguo Sun, Haitao Chen, and Xueying Mao
- Subjects
Adult ,Male ,Hot Temperature ,Food industry ,030309 nutrition & dietetics ,Gas Chromatography-Mass Spectrometry ,Young Adult ,03 medical and health sciences ,0404 agricultural biotechnology ,food ,Onions ,Cooked vegetable ,Humans ,Cooking ,Food science ,Flavor ,0303 health sciences ,biology ,business.industry ,Chemistry ,food and beverages ,04 agricultural and veterinary sciences ,biology.organism_classification ,040401 food science ,food.food ,Soybean Oil ,Allium fistulosum ,Taste ,Odorants ,Allium ,Female ,business ,Food Science ,Oil temperature - Abstract
Fried allium oil has been widely used in traditional Chinese home cooking and recently has grown in popularity in the food manufacturing industry. Thus, physical and chemical changes during frying process were measured to investigate the flavor formation mechanism in green onion (Allium fistulosum L.) deep-fried oil. With the increase of the oil temperature, important variations took place when the temperature rose above 140 °C during the whole frying process. A detailed study of these changes was made from both macro and micro aspects. From a macro perspective, sensory attributes including burnt, fried, oily, cooked vegetable and salty were strengthened. Meanwhile, the reference points of the oil samples on the fingerprint chart were distinguishable from others by electronic nose. In addition, contents of furans and furanones, sulfur-containing compounds, aldehydes and alcohols increased sharply according to SAFE-GC-MS analysis from a microscopic point of view, and contents of unsaturated fatty acids dropped remarkably while the saturated ones increased. These changes were considered to be caused by interactions between carbohydrates, proteins and fats in the deep-fried system and thermo degradations of sugars, amino acids and fats. The results indicated that the stage, when frying at temperatures ranging from 140 °C to 165 °C, was the most significant period for the flavor formation of the deep-fried oil.
- Published
- 2019
- Full Text
- View/download PDF
32. Phytanic acid activates PPARα to promote beige adipogenic differentiation of preadipocytes
- Author
-
Hanning Wang, Xueying Mao, and Min Du
- Subjects
0301 basic medicine ,Phytanic acid ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,030209 endocrinology & metabolism ,AMP-Activated Protein Kinases ,Biology ,Biochemistry ,Article ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Mediator ,3T3-L1 Cells ,Animals ,PPAR alpha ,Adipocytes, Beige ,Phosphorylation ,Progenitor cell ,Receptor ,Oxazoles ,Molecular Biology ,PRDM16 ,Gene knockdown ,Adipogenesis ,Nutrition and Dietetics ,Cell Differentiation ,Mitochondria ,Cell biology ,Oxygen ,Phytanic Acid ,030104 developmental biology ,Mitochondrial biogenesis ,chemistry ,Gene Knockdown Techniques ,Receptors, Adrenergic, beta-3 ,Tyrosine - Abstract
A better understanding of the mechanisms of beige and brown adipogenesis is needed for developing strategies to prevent and treat obesity and associated metabolic disorders. Phytanic acid (PA) exists in a wide range of foods, especially in milk fat and marine foods, but its effects on obesity and beige adipogenesis remain poorly defined. The objective is to investigate the effects and regulatory mechanisms of PA in the beige adipogenesis. In 3T3-L1 preadipocytes, PA elevated the expression of brown adipogenic markers, suggesting that PA promotes beige adipogenic differentiation in committed adipogenic cells. In uncommitted C3H10T1/2 cells, while PA increased PGC1α expression, it did not increase brown adipogenic regulators PRDM16 or UCP1 expression, suggesting that PA had no significant effects on brown adipocyte commitment. PA also enhanced mitochondrial biogenesis and oxygen consumption. Promotion of both mitochondriogenesis and beige adipogenic differentiation were blocked by using PPARα antagonist or with Pparα knockdown, showing that PA-mediated beige/brown adipogenic differentiation is dependent on PPARα. Additionally, the PA-regulated effect is independent on β3-adrenergic receptor. Taken together, PA promotes beige adipogenic differentiation, but not the commitment of progenitor cells to the brown adipocyte lineage. PPARα is a key mediator during PA-induced beige/brown adipogenic differentiation.
- Published
- 2019
- Full Text
- View/download PDF
33. Bovine α-lactalbumin hydrolysates (α-LAH) attenuate high-fat diet induced nonalcoholic fatty liver disease by modulating hepatic lipid metabolism in C57BL/6J mice
- Author
-
Min Du, Jiajia Song, Xueying Mao, and Jing Gao
- Subjects
0301 basic medicine ,medicine.medical_specialty ,PPARγ ,Medicine (miscellaneous) ,Blood lipids ,medicine.disease_cause ,PPARα ,Hydrolysate ,03 medical and health sciences ,0404 agricultural biotechnology ,Internal medicine ,NAFLD ,Gene expression ,Nonalcoholic fatty liver disease ,medicine ,TX341-641 ,Bovine α-lactalbumin hydrolysates ,Lactalbumin ,Liver injury ,030109 nutrition & dietetics ,Nutrition and Dietetics ,Chemistry ,Nutrition. Foods and food supply ,nutritional and metabolic diseases ,04 agricultural and veterinary sciences ,Metabolism ,medicine.disease ,040401 food science ,Endocrinology ,High-fat diet ,Oxidative stress ,Food Science - Abstract
The effect of bovine α-lactalbumin hydrolysates (α-LAH) on attenuating high-fat diet (HFD) induced nonalcoholic fatty liver disease (NAFLD) was investigated. C57BL/6J mice were fed with HFD for 8 weeks to mimic the clinical features of NAFLD, and then were fed with HFD and bovine α-LAH at different doses (100, 200 and 400 mg/kg b.w.) for another 12 weeks to investigate the beneficial effects of bovine α-LAH on NAFLD. Our data showed that bovine α-LAH markedly reversed the increase of body weight gain, tissue weight, serum lipids, liver injury markers, and serum pro-inflammatory cytokines induced by HFD in C57BL/6J mice. Bovine α-LAH supplementation also ameliorated fat accumulation and oxidative stress, down-regulated PPARγ associated gene expression, and up-regulated PPARα associated gene expression in the liver of mice fed HFD. These findings suggested that bovine α-LAH is effective in attenuating HFD induced NAFLD in C57BL/6J mice.
- Published
- 2019
34. G-protein-coupled receptors function as logic gates for nanoparticle binding using systems and synthetic biology approach
- Author
-
Dong-Qing Wei, Aman Chandra Kaushik, Cheng-Dong Li, Yan Li, Shakti Sahi, and Xueying Mao
- Subjects
0303 health sciences ,Virtual screening ,Materials science ,biology ,Mechanical Engineering ,Systems biology ,02 engineering and technology ,021001 nanoscience & nanotechnology ,Condensed Matter Physics ,Cell biology ,03 medical and health sciences ,Synthetic biology ,GPR119 ,Downregulation and upregulation ,Mechanics of Materials ,Rhodopsin ,biology.protein ,General Materials Science ,0210 nano-technology ,Receptor ,030304 developmental biology ,G protein-coupled receptor - Abstract
G-protein-coupled receptor 142 (GPR142) belongs to rhodopsin family. GPR142 and GPR119, both Gq-coupled receptors, are expressed in pancreatic β cells of pancreas; their activation eventually leads to triggering of insulin secretion. In this paper, through a systems and synthetic biology approach, the effect of a common hit compound has been investigated in GPR142 and GPR119 pathways. This hit that has the potential to be developed as a lead for nanodrug was obtained through high-throughput virtual screening. The hit compound was further docked with nanoparticles (GOLD, SPION, and CeO2). The probable effect of this potential hit on insulin secretion in type 2 diabetes and its dynamic behavior was explored. Kinetic simulation was performed for cross-validation of its role in both the pathways. This study opens up a probable avenue in therapy of type 2 diabetes through regulation of GPR142 and GPR119 receptors. The biological circuit constructed may further have an application as a modulator to control the up- and downregulation of the biochemical pathway and can be implemented as sensors or nanochips for therapy.
- Published
- 2019
- Full Text
- View/download PDF
35. Prevention of breast cancer by dietary polyphenols—role of cancer stem cells
- Author
-
Min Du, Xueying Mao, and Hao-Feng Gu
- Subjects
Poor prognosis ,Curcumin ,business.industry ,Mechanism (biology) ,food and beverages ,Polyphenols ,Cancer ,Antineoplastic Agents ,Breast Neoplasms ,General Medicine ,Malignancy ,medicine.disease ,Article ,Industrial and Manufacturing Engineering ,Breast cancer ,Cancer stem cell ,Cancer cell ,Neoplastic Stem Cells ,medicine ,Cancer research ,Humans ,business ,Food Science - Abstract
Breast cancer is a common malignancy with poor prognosis. Cancer cells are heterogeneous and cancer stem cells (CSCs) are primarily responsible for tumor relapse, treatment-resistance and metastasis, so for breast cancer stem cells (BCSCs). Diets are known to be associated with carcinogenesis. Food-derived polyphenols are able to attenuate the formation and virulence of BCSCs, implying that these compounds and their analogs might be promising agents for preventing breast cancer. In the present review, we summarized the origin and surface markers of BCSCs and possible mechanisms responsible for the inhibitory effects of polyphenols on BCSCs. The suppressive effects of common dietary polyphenols against BCSCs, such as curcumin, epigallocatechin gallate (EGCG) and related polyphenolic compounds were further discussed.
- Published
- 2019
- Full Text
- View/download PDF
36. Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry
- Author
-
Sara Benlloch, Roger L. Milne, Azad Hassan Abdul Razack, José Manuel Ruiz-Dominguez, Steven Joniau, Maria P. Silva, Martin Andreas Røder, Constance Turman, Anne-Maree Haynes, Jin Ling, Robert N. Hoover, Jong Y. Park, Johanna Schleutker, Brian E. Henderson, Amy Hutchinson, Stephanie J. Weinstein, Manolis Kogevinas, Melissa Papargiris, Monique J. Roobol, Gill Barnett, Wayne D. Tilley, Elio Riboli, Samantha E.T. Larkin, Melissa C. Southey, Michelle Guy, Jeanette T. Bensen, Henrik Grönberg, Fredrick R. Schumacher, Karina Dalsgaard Sørensen, Davor Lessel, Carin Cavalli-Bjoerkman, Tomislav Kuliš, Barry S. Rosenstein, Paula Kujala, Michael Davis, Andrzej M. Kierzek, Antonio Finelli, Gerald L. Andriole, Leire Moya, Antonio Gómez-Caamaño, Demetrius Albanes, Jianming Guo, Lisa F. Newcomb, Koveela Govindasami, Ji Lin, Gert De Meerleer, Manuel Luedeke, Richard M. Martin, Zeljko Kastelan, Kay-Tee Khaw, Ruth C. Travis, Rebecca Elliott, Alexandre R. Zlotta, Xin Guo, Kirsi Talala, Yangling Zhang, Lorelei A. Mucci, Marie Sanchez, Paul D.P. Pharoah, Mariona Bustamante, Peter Klarskov, Aleksandrina Vlahova, Srilakshmi Srinivasan, Aik T. Ong, David E. Neal, Sylvie Cénée, Esther M. John, Sonja I. Berndt, Kan Wang, Peter Iversen, Harry Ostrer, Michael Borre, Freddie C. Hamdy, Christopher A. Haiman, Ji Wu, Florence Menegaux, Jacek Marzec, Sara S. Strom, David P. Dearnaley, Jyotsna Batra, Piet Ost, Mariana C. Stern, Kim De Ruyck, Hyun Soo Park, Trina Yeadon, Elenko Popov, Yudong Wu, Svetlana Christova, Thomas Van den Broeck, Loic Le Marchand, Daniel J. Schaid, Babu Zachariah, Sune F. Nielsen, Mary-Anne Kedda, Judith A. Clements, Olivier Cussenot, Robert Szulkin, Shiro Saito, Andrew Evans, Douglas F. Easton, Gemma Castaño-Vinyals, Steve Hazel, Thérèse Truong, Guomin Wang, Katarina Cuk, Ants Toi, Rosalind A. Eeles, Darina Kachakova, Lourdes Mengual, Lisa G. Horvath, Yuan Chun Ding, Catharine M L West, Ana Carballo, Suzanne K. Chambers, Aurelie Vogt, Angela Cox, Daniel W. Lin, Dominika Wokołorczyk, Manuela Gago-Dominguez, Stephen J. Chanock, Federico Canzian, Aleksandra Klim, Tokhir Dadaev, Kathleen Herkommer, Tihomir Dikov, Lovise Maehle, Jasmine Lim, Janet L. Stanford, Martin Eklund, Guido Jenster, Soo-Hwang Teo, Teemu J. Murtola, Torben F. Ørntoft, Stella Koutros, Christa Stegmaier, Sofia Maia, Mitchell J. Machiela, Lisa A. Cannon-Albright, Clare Berry, Pamela Saunders, Lluís Cecchini, Jeri Kim, Radka Kaneva, Brigitte Trétarre, Anne George, Meir J. Stampfer, Marija Gamulin, Meng H. Tan, Angela Morgan, Jenny L Donovan, Graham G. Giles, Geraldine Cancel-Tassin, Neil Fleshner, Shannon K. McDonnell, Hardeep Ranu, Naomi Livni, Kimmo Taari, Sarah L. Kerns, Csilla Sipeky, Alicja Wolk, Edward Giovannucci, Ninghan Feng, Marta Cardoso, Jan-Erik Johansson, Catherine M. Tangen, Guangwen Cao, Adam S. Kibel, Robert J. MacInnis, Bernd Holleczek, Sarah J Lewis, Bo Zhou, Michael Broms, Maria Elena Martinez, Renea A. Taylor, Børge G. Nordestgaard, Fritz H. Schröder, Ali Amin Al Olama, Sue A. Ingles, Markus Aly, Jie Li, Lori S. Tillmans, Ana Vega, Patricia Calvo, Christopher J. Logothetis, David V. Conti, Miguel Aguado, Inés Gómez-Acebo, Tobias Nordström, Meiling Li, Elaine A. Ostrander, C.H. Bangma, Cyril Fisher, Joanne F. Aitken, Matthew Parliament, Gail P. Risbridger, John L. Hopper, Takashi Imai, Belynda Hicks, Victoria L. Stevens, Cezary Cybulski, G Marsden, Brian D. Carter, Vanessa M. Hayes, Nawaid Usmani, Vanio Mitev, Shan-Chao Zhao, Margaret Cook, Milan S. Geybels, Phyllis J. Goodman, Mark N. Brook, Nora Pashayan, Timothy J. Key, Yongwei Yu, Xavier Rebillard, David J. Hunter, Laura Fachal, Javier Llorca, Afshan Siddiq, Claire Aukim-Hastie, Trinidad Dierssen-Sotos, Walther Vogel, Angel Carracedo, Laura E. Beane Freeman, Julio M. Pow-Sang, Hardev Pandha, Robert A. Gardiner, Shaun M. Riska, Yong-Jie Lu, Zan Sun, Ramón Lobato-Busto, Ami Karlsson, Hongwei Zhang, Guoping Ren, Jing Ma, Huihai Wu, Søren M. Bentzen, John Pedersen, Claire Mulot, Girish S. Kulkarni, Jan Lubinski, Antonio Alcaraz, Jose E. Castelao, Athene Lane, Rasmus Bisbjerg, Thomas A. Sellers, Robert J. Hamilton, Jianfeng Xu, Sofie De Langhe, Artitaya Lophatananon, Maren Weisher, Agnieszka Michael, Yves Akoli Koudou, Niclas Håkansson, Alison M. Dunning, Hubert Thierens, Matthew L. Freedman, Kenneth Muir, Ian M. Thompson, Ian Whitmore, Susan L. Neuhausen, Chavdar Slavov, Wojciech Kluzniak, Laurence N. Kolonel, Lisa M. Butler, Teuvo L.J. Tammela, Alison Thwaites, Theodorus van der Kwast, Liesel M. FitzGerald, Thomas J. Schnoeller, Hermann Brenner, Christiane Maier, Amanda B. Spurdle, Jan Adolfsson, Atanaska Mitkova, Peter Kraft, Paula Peleteiro, Pär Stattin, Xin Sheng, Paul D. Brown, Ron H.N. van Schaik, Zsofia Kote-Jarai, Susan M. Gapstur, Paul A. Townsend, Edward J. Saunders, Bettina F. Drake, Stephen N. Thibodeau, Fredrik Wiklund, Paula Paulo, Esther Gracia-Lavedan, Xueying Mao, Marco Matejcic, Neil G. Burnet, A. L. Eckert, Manuel R. Teixeira, Sara Lindström, Weiyang He, Hui-Yi Lin, Suzanne Kolb, Linda Steele, Philipp Bohnert, Anssi Auvinen, Eli Marie Grindedal, Frank Claessens, and Kathryn L. Penney
- Subjects
Urologic Diseases ,0301 basic medicine ,Oncology ,medicine.medical_specialty ,Science ,MEDLINE ,General Physics and Astronomy ,02 engineering and technology ,General Biochemistry, Genetics and Molecular Biology ,Germline ,03 medical and health sciences ,Internal medicine ,medicine ,PRACTICAL Consortium ,lcsh:Science ,Cancer ,Prostate cancer risk ,Multidisciplinary ,business.industry ,Prostate Cancer ,Published Erratum ,General Chemistry ,021001 nanoscience & nanotechnology ,medicine.disease ,Spelling ,3. Good health ,030104 developmental biology ,Variation (linguistics) ,lcsh:Q ,0210 nano-technology ,business - Abstract
The original version of this Article contained an error in the spelling of the author Manuela Gago-Dominguez, which was incorrectly given as Manuela G. Dominguez. This has now been corrected in both the PDF and HTML versions of the Article.
- Published
- 2019
- Full Text
- View/download PDF
37. Milk Polar Lipids Supplementation to Obese Rats During Pregnancy and Lactation Benefited Skeletal Outcomes of Male Offspring
- Author
-
Min Du, Xueying Mao, Lihua Han, and Fazheng Ren
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,Offspring ,Diet, High-Fat ,Gonadotropin-Releasing Hormone ,Rats, Sprague-Dawley ,03 medical and health sciences ,Insulin resistance ,Pregnancy ,Internal medicine ,Lactation ,medicine ,Weaning ,Animals ,Obesity ,Insulin-Like Growth Factor I ,Glycoproteins ,Fetus ,030109 nutrition & dietetics ,Bone Development ,business.industry ,Lipid Droplets ,Maternal Nutritional Physiological Phenomena ,medicine.disease ,Growth hormone–releasing hormone ,Lipids ,030104 developmental biology ,Endocrinology ,medicine.anatomical_structure ,Milk ,Hypothalamus ,Growth Hormone ,Dietary Supplements ,Female ,Glycolipids ,Insulin Resistance ,business ,Food Science ,Biotechnology - Abstract
Scope Dietary intervention to obese dams during pregnancy and lactation period provides avenues for improving metabolic profiles of the offspring. In the current study, the effects of polar lipids-enriched milk fat globule membrane (MFGM-PL) supplementation to obese dams during pregnancy and lactation on the skeletal outcomes of male offspring are investigated. Methods and results MFGM-PL is supplemented to obese rats induced by high-fat diet during pregnancy and lactation at a dose of 400 mg kg-1 body weight. Results show that maternal MFGM-PL supplementation significantly ameliorates the stunted skeletal growth of male offspring at weaning. In adulthood offspring, maternal MFGM-PL supplementation protects against high-fat diet (HFD)-induced bone microstructure degeneration and bone marrow adipocyte accumulation. Further investigation shows that maternal supplementation of MFGM-PL significantly ameliorates insulin resistance and increases the mRNA expression of growth hormone releasing hormone (GHRH) in the hypothalamus of HFD offspring. The growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis is subsequently enhanced in MFGM-PL + HFD offspring, contributing to the beneficial skeletal outcomes. Conclusion The findings suggest that maternal MFGM-PL supplementation of HFD dam during pregnancy and lactation shows desirable effects on fetal skeletal development, with lasting beneficial programming impacts on skeletal outcomes of offspring.
- Published
- 2021
38. NeuroPpred-Fuse: an interpretable stacking model for prediction of neuropeptides by fusing sequence information and feature selection methods
- Author
-
Xueying Mao, Mingming Jiang, Yanjing Wang, Tianhang Chen, Yanyi Chu, Shenggan Luo, Yi Xiong, Xue Jiang, Yatong Liu, Bowen Zhao, Dong-Qing Wei, and Qiankun Wang
- Subjects
Computer science ,Generalization ,business.industry ,Neuropeptides ,Computational Biology ,Pattern recognition ,Feature selection ,ENCODE ,Models, Biological ,Machine Learning ,Tree (data structure) ,Range (mathematics) ,Test set ,Artificial intelligence ,Layer (object-oriented design) ,business ,Molecular Biology ,Classifier (UML) ,Algorithms ,Information Systems - Abstract
Neuropeptides acting as signaling molecules in the nervous system of various animals play crucial roles in a wide range of physiological functions and hormone regulation behaviors. Neuropeptides offer many opportunities for the discovery of new drugs and targets for the treatment of neurological diseases. In recent years, there have been several data-driven computational predictors of various types of bioactive peptides, but the relevant work about neuropeptides is little at present. In this work, we developed an interpretable stacking model, named NeuroPpred-Fuse, for the prediction of neuropeptides through fusing a variety of sequence-derived features and feature selection methods. Specifically, we used six types of sequence-derived features to encode the peptide sequences and then combined them. In the first layer, we ensembled three base classifiers and four feature selection algorithms, which select non-redundant important features complementarily. In the second layer, the output of the first layer was merged and fed into logistic regression (LR) classifier to train the model. Moreover, we analyzed the selected features and explained the feasibility of the selected features. Experimental results show that our model achieved 90.6% accuracy and 95.8% AUC on the independent test set, outperforming the state-of-the-art models. In addition, we exhibited the distribution of selected features by these tree models and compared the results on the training set to that on the test set. These results fully showed that our model has a certain generalization ability. Therefore, we expect that our model would provide important advances in the discovery of neuropeptides as new drugs for the treatment of neurological diseases.
- Published
- 2021
39. Supplementation of milk polar lipids to obese dams improves neurodevelopment and cognitive function in male offspring
- Author
-
Min Du, Xueying Mao, Han Gong, and Qichen Yuan
- Subjects
0301 basic medicine ,Central Nervous System ,Male ,medicine.medical_specialty ,Offspring ,Biology ,Diet, High-Fat ,Biochemistry ,Rats, Sprague-Dawley ,03 medical and health sciences ,0302 clinical medicine ,Insulin resistance ,Cognition ,Neurotrophic factors ,Pregnancy ,Internal medicine ,Lactation ,Genetics ,medicine ,Hyperinsulinemia ,Weaning ,Animals ,Receptor, trkB ,Obesity ,Cyclic AMP Response Element-Binding Protein ,Molecular Biology ,Prenatal Nutritional Physiological Phenomena ,Brain-Derived Neurotrophic Factor ,Gene Expression Regulation, Developmental ,medicine.disease ,Lipids ,Rats ,030104 developmental biology ,medicine.anatomical_structure ,Endocrinology ,Milk ,Dietary Supplements ,Female ,030217 neurology & neurosurgery ,Biotechnology - Abstract
Milk contains about 4% fat globules with its surface covered by polar lipids. Despite the abundant consumption of dairy products, the biological effects of dietary milk polar lipids on metabolic health have only been sparsely examined. Maternal obesity results in neurodevelopmental disorders and cognitive impairment in offspring. Considering the importance of maternal nutrition, the effects of polar lipids-enriched milk fat globule membrane (MFGM-PL) supplementation to dams during pregnancy and lactation on neurodevelopment and its long-term programming effects on offspring cognition were examined. Female Sprague-Dawley rats consumed 8-week control diet (CON) or high-fat diet (HFD) to induce obesity before mating. Then, female rats were fed CON or HFD with or without the supplementation of 400 mg/kg body weight MFGM-PL during pregnancy and lactation. The offspring were fed 11-week HFD after weaning. MFGM-PL supplementation to obese dams suppressed body weight gain and hyperinsulinemia in both dams and offspring. Offspring born to obese dams displayed delayed neurological reflexes development, impaired neurogenesis before weaning, and cognitive impairment in adulthood, which were recovered by maternal MFGM-PL supplementation. Insulin resistance and aberrant brain-derived neurotrophic factor signaling were induced in the hippocampus of neonatal and adult offspring due to maternal and progeny HFD, but recovered by maternal MFGM-PL administration. This study demonstrates that maternal MFGM-PL supplementation can promote neurodevelopment and exert long-term effects against HFD-induced cognitive impairment in offspring via alleviating hippocampal insulin resistance. Hence, MFGM-PL is a promising ingredient for exerting beneficial programming effects on the brain health of offspring.
- Published
- 2021
40. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
- Author
-
Brian D. Carter, Gert De Meerleer, Michael B. Cook, Paul A. Townsend, Kim De Ruyck, Edward J. Saunders, Christopher A. Haiman, Atushi Takahashi, Sonja I. Berndt, Florence Menegaux, Cezary Cybulski, Barbara Nemesure, Loic Le Marchand, Sune F. Nielsen, Demetrius Albanes, Robert J. Hamilton, Ninghan Feng, Stella Koutros, Stephen J. Chanock, Wei Zheng, Thomas A. Sellers, Rick A. Kittles, Craig C. Teerlink, Stephen N. Thibodeau, Marija Gamulin, Artitaya Lophatananon, Niclas Håkansson, Fredrik Wiklund, Roberta McKean-Cowdin, Yuan Chun Ding, Nora Pashayan, Timothy J. Key, Børge G. Nordestgaard, Shannon K. McDonnell, Jong Y. Park, Laura Fachal, Martin Andreas Røder, Johanna Schleutker, Edward Giovannucci, Anssi Auvinen, Hardev Pandha, Maria Elena Martinez, Mitchell J. Machiela, Gill Barnett, Melissa C. Southey, Graham G. Giles, Barry S. Rosenstein, Stephen Watya, Bernd Holleczek, Pascal Blanchet, Agnieszka Michael, William J. Blot, James L. Mohler, Jack A. Taylor, Sarah L. Kerns, Adam S. Kibel, Piet Ost, Ana Vega, Richard M. Martin, Jennifer J. Hu, Nicholas Mancuso, Yukihide Momozawa, Robert J. MacInnis, Sue A. Ingles, Maureen Sanderson, Kai Uwe Saum, Markus Aly, Robert Szulkin, Davor Lessel, Hermann Brenner, Yves Akoli Koudou, Jan Lubinski, Mina Torres, Anselm Hennis, Eli Marie Grindedal, Csilla Sipeky, Susan L. Neuhausen, Alison M. Dunning, Alicja Wolk, Adam B. Murphy, Brandi Weaver, Mariana C. Stern, Paula Paulo, Stephanie J. Weinstein, Xueying Mao, Tobias Nordström, Neil Fleshner, Tokhir Dadaev, Teuvo L.J. Tammela, Jay H. Fowke, Tomislav Kuliš, Steven Joniau, Yudong Wu, Rosalind A. Eeles, Shan Chao Zhao, Kenneth Muir, Mark N. Brook, Hidewaki Nakagawa, Freddie C. Hamdy, Karina Dalsgaard Sørensen, Linda Steele, Alisha Chou, Dominika Wokołorczyk, Peggy Wan, Martin Eklund, Laurent Brureau, Lisa A. Cannon-Albright, Lilit C. Moss, Daniel J. Schaid, Luc Multigner, Benjamin A. Rybicki, Xin Sheng, Constance Turman, Ron H.N. van Schaik, Radka Kaneva, Zsofia Kote-Jarai, Frank Claessens, Katarina Cuk, Kay-Tee Khaw, Chad D. Huff, Henrik Grönberg, Kathryn L. Penney, Geraldine Cancel-Tassin, Eric A. Klein, Masashi Fujita, Jennifer Cullen, Michael Borre, Jenny L Donovan, Dana C. Crawford, Antonio Gómez-Caamaño, David V. Conti, Manuel Luedeke, Maya Ghoussaini, Janet L. Stanford, Peter Kraft, Ian M. Thompson, Koichi Matsuda, Soo-Hwang Teo, Christopher J. Logothetis, Robin J. Leach, Monique J. Roobol, Manuel R. Teixeira, Jose Esteban Castelao, Sara S. Strom, Vanio Mitev, Stig E. Bojesen, David J. Hunter, Wayne D. Tilley, Jyotsna Batra, Gerald L. Andriole, Christine Neslund-Dudas, Sara Lindström, Guido Jenster, Catherine M. Tangen, William S. Bush, Maren Weischer, Chavdar Slavov, Thomas J. Schnoeller, Javier Llorca, Claire Aukim-Hastie, Nawaid Usmani, Lisa G. Horvath, Daniel W. Lin, Esther M. John, Burcu F. Darst, Milan S. Geybels, Phyllis J. Goodman, Lynne R. Wilkens, Ali Amin Al Olama, Lorelei A. Mucci, Peter Iversen, Christiane Maier, Victoria L. Stevens, Andreia Brandão, Graham Casey, Neil G. Burnet, Ann W. Hsing, Hongwei Zhang, Laura E. Beane Freeman, Susan M. Gapstur, Sara Benlloch, James E. Mensah, Marie-Élise Parent, Jianfeng Xu, Bettina F. Drake, Jeannette T. Bensen, Azad Hassan Abdul Razack, Edward D. Yeboah, David E. Neal, John D. Carpten, Ruth C. Travis, Thomas J. Hoffmann, Thomas Van den Broeck, Jeri Kim, Ali Sahimi, Gemma Castaño-Vinyals, Alexander Lubwama, Leire Moya, Elio Riboli, Douglas F. Easton, Suzanne K. Chambers, Yong-Jie Lu, Melinda C. Aldrich, Manuela Gago-Dominguez, John S. Witte, Matthew Parliament, Gail P. Risbridger, Samantha E.T. Larkin, Lisa F. Newcomb, Fredrick R. Schumacher, Shiv Srivastava, Jasmine Lim, Meir J. Stampfer, Harry Ostrer, Judith A. Clements, Thérèse Truong, Catharine M L West, Zan Sun, Olivier Cussenot, Gyorgy Petrovics, Lovise Maehle, Elizabeth T. H. Fontham, William B. Isaacs, Hui Yi Lin, Rohit Varma, Elaine A. Ostrander, Manolis Kogevinas, Robert N. Hoover, Sandeep Singhal, Antonio Finelli, and Stephen K. Van Den Eeden
- Subjects
0303 health sciences ,business.industry ,Published Erratum ,MEDLINE ,Genome-wide association study ,Computational biology ,Biology ,medicine.disease ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Meta-analysis ,Genetics ,medicine ,Susceptibility locus ,06 Biological Sciences, 11 Medical and Health Sciences ,Personalized medicine ,Genetic risk ,business ,030217 neurology & neurosurgery ,030304 developmental biology ,Developmental Biology - Abstract
In the version of this article originally published, the names of the equally contributing authors and jointly supervising authors were switched. The correct affiliations are: “These authors contributed equally: David V. Conti, Burcu F. Darst. These authors jointly supervised this work: David V. Conti, Rosalind A. Eeles, Zsofia Kote-Jarai, Christopher A. Haiman.” The error has been corrected in the HTML and PDF versions of the article.
- Published
- 2021
41. The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing
- Author
-
Tianyu Guo, Yang Wang, Jing Jia, Xueying Mao, Elzbieta Stankiewicz, Glenda Scandura, Edwina Burke, Lei Xu, Jacek Marzec, Caitlin R. Davies, Jiaying Jasmin Lu, Prabhakar Rajan, Alistair Grey, Karen Tipples, John Hines, Sakunthala Kudahetti, Tim Oliver, Thomas Powles, Constantine Alifrangis, Manish Kohli, Greg Shaw, Wen Wang, Ninghan Feng, Jonathan Shamash, Daniel Berney, Liang Wang, and Yong-Jie Lu
- Subjects
Oncology ,medicine.medical_specialty ,medicine.drug_class ,miR-423-3p ,urologic and male genital diseases ,Cell and Developmental Biology ,Prostate cancer ,Castration Resistance ,Antigen ,Internal medicine ,microRNA ,medicine ,lcsh:QH301-705.5 ,Original Research ,Predictive biomarker ,plasma exosome miRNA ,business.industry ,Mirna sequencing ,Cell Biology ,prostate cancer ,castration-resistance development ,medicine.disease ,Androgen ,lcsh:Biology (General) ,biomarker ,Biomarker (medicine) ,business ,Developmental Biology - Abstract
Castration-resistant prostate cancer (CRPC) is the major cause of death from prostate cancer. Biomarkers to improve early detection and prediction of CRPC especially using non-invasive liquid biopsies could improve outcomes. Therefore, we investigated the plasma exosomal miRNAs associated with CRPC and their potential for development into non-invasive early detection biomarkers for resistance to treatment. RNA-sequencing, which generated approximately five million reads per patient, was performed to identify differentially expressed plasma exosomal miRNAs in 24 treatment-naive prostate cancer and 24 CRPC patients. RT-qPCR was used to confirm the differential expressions of six exosomal miRNAs, miR-423-3p, miR-320a, miR-99a-5p, miR-320d, miR-320b, and miR-150-5p (p = 7.3 × 10−8, 0.0020, 0.018, 0.0028, 0.0013, and 0.0058, respectively) firstly in a validation cohort of 108 treatment-naive prostate cancer and 42 CRPC patients. The most significant differentially expressed miRNA, miR-423-3p, was shown to be associated with CRPC with area under the ROC curve (AUC) = 0.784. Combining miR-423-3p with prostate-specific antigen (PSA) enhanced the prediction of CRPC (AUC = 0.908). A separate research center validation with 30 treatment-naive and 30 CRPC patients also confirmed the differential expression of miR-423-3p (p = 0.016). Finally, plasma exosomal miR-423-3p expression in CRPC patients was compared to 36 non-CRPC patients under androgen depletion therapy, which showed significantly higher expression in CRPC than treated non-CRPC patients (p < 0.0001) with AUC = 0.879 to predict CRPC with no difference between treatment-naive and treated non-CRPC patients. Therefore, our findings demonstrate that a number of plasma exosomal miRNAs are associated with CRPC and miR-423-3p may serve as a biomarker for early detection/prediction of castration-resistance.
- Published
- 2021
- Full Text
- View/download PDF
42. The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis
- Author
-
Claude Chelala, Stefano Pirrò, Daniel M. Berney, Emanuela Gadaleta, Sakunthala C. Kudahetti, Yanan Zhu, Guoping Ren, Yong-Jie Lu, Xueying Mao, Bernard V. North, Jun Wang, Jacek Marzec, Luis Beltran, Elzbieta Stankiewicz, Amar Ahmad, Solene-Florence Kammerer-Jacquet, and Helen Ross-Adams
- Subjects
0301 basic medicine ,Cancer Research ,Candidate gene ,Microarray ,mRNA ,Translational research ,Disease ,Computational biology ,Biology ,lcsh:RC254-282 ,Article ,Transcriptome ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Prostate ,medicine ,data integration ,Intraepithelial neoplasia ,transcriptomic ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,prostate cancer ,RNAseq ,tumorigenesis ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis - Abstract
Simple Summary There is a tremendous amount of gene expression information available for prostate cancer, but very few tools exist to combine the disparate datasets generated across sample types and technical platforms. We present a method of integrating different types of expression data from different study cohorts to increase analytic power, and improve our understanding of the molecular changes underlying the development and progression of prostate cancer from normal to advanced disease. Using this approach, we identified nine additional disease stage-specific candidate genes with prognostic significance, which were not identified in any one study alone. We have developed a free online tool summarizing our results, and making the complete combined dataset available for further translational research. Abstract Next-generation sequencing of primary tumors is now standard for transcriptomic studies, but microarray-based data still constitute the majority of available information on other clinically valuable samples, including archive material. Using prostate cancer (PC) as a model, we developed a robust analytical framework to integrate data across different technical platforms and disease subtypes to connect distinct disease stages and reveal potentially relevant genes not identifiable from single studies alone. We reconstructed the molecular profile of PC to yield the first comprehensive insight into its development, by tracking changes in mRNA levels from normal prostate to high-grade prostatic intraepithelial neoplasia, and metastatic disease. A total of nine previously unreported stage-specific candidate genes with prognostic significance were also found. Here, we integrate gene expression data from disparate sample types, disease stages and technical platforms into one coherent whole, to give a global view of the expression changes associated with the development and progression of PC from normal tissue through to metastatic disease. Summary and individual data are available online at the Prostate Integrative Expression Database (PIXdb), a user-friendly interface designed for clinicians and laboratory researchers to facilitate translational research.
- Published
- 2021
43. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
- Author
-
Paul A. Townsend, Edward J. Saunders, Hidewaki Nakagawa, Manuel R. Teixeira, Graham Casey, Demetrius Albanes, Christine Neslund-Dudas, Sara Lindström, William S. Bush, Maren Weischer, Lisa A. Cannon-Albright, Rick A. Kittles, Peggy Wan, Martin Eklund, Stephen N. Thibodeau, Burcu F. Darst, Fredrik Wiklund, Nicholas Mancuso, Jeri Kim, Jong Y. Park, Johanna Schleutker, Maureen Sanderson, Samantha E.T. Larkin, Radka Kaneva, Hongwei Zhang, Daniel J. Schaid, Luc Multigner, Marie-Élise Parent, Robert Szulkin, Fredrick R. Schumacher, Geraldine Cancel-Tassin, Jianfeng Xu, Gill Barnett, Melissa C. Southey, Yuan Chun Ding, Alexander Lubwama, Maria Elena Martinez, Manolis Kogevinas, Linda Steele, Laurent Brureau, Shiv Srivastava, Maya Ghoussaini, Alison M. Dunning, Adam B. Murphy, Kenneth Muir, Edward Giovannucci, Mitchell J. Machiela, James L. Mohler, Jack A. Taylor, Robert N. Hoover, Sandeep Singhal, Chavdar Slavov, Guido Jenster, Frank Claessens, Neil Fleshner, Sara Benlloch, Gert De Meerleer, Michael B. Cook, Zan Sun, Harry Ostrer, Pascal Blanchet, Lynne R. Wilkens, Ali Amin Al Olama, Sue A. Ingles, Markus Aly, Jay H. Fowke, Agnieszka Michael, Yves Akoli Koudou, Victoria L. Stevens, Kathryn L. Penney, Ana Vega, Xin Sheng, Ron H.N. van Schaik, Zsofia Kote-Jarai, Kim De Ruyck, Christopher A. Haiman, Atushi Takahashi, Florence Menegaux, Judith A. Clements, Stephen K. Van Den Eeden, Brian D. Carter, Wayne D. Tilley, Antonio Finelli, Jennifer J. Hu, Hermann Brenner, Thomas Van den Broeck, Shan Chao Zhao, Azad Hassan Abdul Razack, Edward D. Yeboah, Sonja I. Berndt, Barbara Nemesure, Mark N. Brook, David V. Conti, Katarina Cuk, Teuvo L.J. Tammela, Ali Sahimi, Stephen J. Chanock, Loic Le Marchand, Gemma Castaño-Vinyals, Sune F. Nielsen, Sara S. Strom, Ann W. Hsing, Roberta McKean-Cowdin, David J. Hunter, Ian M. Thompson, Børge G. Nordestgaard, Jyotsna Batra, Paula Paulo, Masashi Fujita, Jennifer Cullen, Susan M. Gapstur, Sarah L. Kerns, Lorelei A. Mucci, Neil G. Burnet, Xueying Mao, Hui Yi Lin, Rohit Varma, Marija Gamulin, Wei Zheng, Thomas A. Sellers, Adam S. Kibel, Robert J. Hamilton, Leire Moya, Ninghan Feng, Laura E. Beane Freeman, James E. Mensah, Catherine M. Tangen, Shannon K. McDonnell, Matthew Parliament, Davor Lessel, Gail P. Risbridger, Mina Torres, Janet L. Stanford, Bettina F. Drake, Soo-Hwang Teo, Robert J. MacInnis, Stig E. Bojesen, Jeannette T. Bensen, William J. Blot, Stella Koutros, Robin J. Leach, Graham G. Giles, Piet Ost, Artitaya Lophatananon, Laura Fachal, Tomislav Kuliš, Peter Kraft, Monique J. Roobol, Elaine A. Ostrander, Niclas Håkansson, Anselm Hennis, Yukihide Momozawa, Anssi Auvinen, Koichi Matsuda, Steven Joniau, Lisa G. Horvath, Javier Llorca, Claire Aukim-Hastie, Bernd Holleczek, Daniel W. Lin, Gerald L. Andriole, John D. Carpten, Eli Marie Grindedal, Rosalind A. Eeles, Elio Riboli, Constance Turman, Martin Andreas Røder, Yong-Jie Lu, Tobias Nordström, Kai Uwe Saum, Esther M. John, Melinda C. Aldrich, Peter Iversen, Henrik Grönberg, John S. Witte, Andreia Brandão, Eric A. Klein, Olivier Cussenot, Barry S. Rosenstein, Stephen Watya, Jan Lubinski, Douglas F. Easton, Dana C. Crawford, Gyorgy Petrovics, Thomas J. Schnoeller, Richard M. Martin, Stephanie J. Weinstein, Jose Esteban Castelao, Suzanne K. Chambers, Tokhir Dadaev, Karina Dalsgaard Sørensen, Antonio Gómez-Caamaño, Lisa F. Newcomb, Csilla Sipeky, Lovise Maehle, Brandi Weaver, Susan L. Neuhausen, Christiane Maier, Alicja Wolk, Vanio Mitev, Thérèse Truong, Manuel Luedeke, Jenny L Donovan, Mariana C. Stern, Catharine M L West, Manuela Gago-Dominguez, Elizabeth T. H. Fontham, William B. Isaacs, David E. Neal, Christopher J. Logothetis, Alisha Chou, Jasmine Lim, Benjamin A. Rybicki, Kay-Tee Khaw, Meir J. Stampfer, Chad D. Huff, Thomas J. Hoffmann, Michael Borre, Freddie C. Hamdy, Nawaid Usmani, Cezary Cybulski, Craig C. Teerlink, Milan S. Geybels, Nora Pashayan, Timothy J. Key, Phyllis J. Goodman, Hardev Pandha, Ruth C. Travis, Yudong Wu, Dominika Wokołorczyk, Lilit C. Moss, University of Southern California (USC), Keck School of Medicine [Los Angeles], CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), CHU Pointe-à-Pitre/Abymes [Guadeloupe], The institute of cancer research [London], U01CA194393, National Institutes of Health, NA, Achievement Rewards for College Scientists Foundation, Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )-Institut National de la Santé et de la Recherche Médicale (INSERM)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Université d'Angers (UA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Urology, Clinical Chemistry, Darst, Burcu F [0000-0002-6205-4632], Chou, Alisha [0000-0001-7521-6373], Schumacher, Fredrick R [0000-0002-3073-7463], Dadaev, Tokhir [0000-0002-8268-0438], Brook, Mark N [0000-0002-8969-2378], Hoffmann, Thomas J [0000-0001-6893-4449], Takahashi, Atushi [0000-0001-7099-8767], Matsuda, Koichi [0000-0001-7292-2686], Fujita, Masashi [0000-0002-1457-6233], Muir, Kenneth [0000-0001-6429-988X], Stevens, Victoria L [0000-0003-0259-4407], Schleutker, Johanna [0000-0002-1863-0305], Sipeky, Csilla [0000-0002-8853-4722], Auvinen, Anssi [0000-0003-1125-4818], Giles, Graham G [0000-0003-4946-9099], Martin, Richard M [0000-0002-7992-7719], Nordestgaard, Børge G [0000-0002-1954-7220], Bojesen, Stig E [0000-0002-4061-4133], Røder, Martin Andreas [0000-0002-0019-5333], Batra, Jyotsna [0000-0003-4646-6247], Tilley, Wayne [0000-0003-1893-2626], Risbridger, Gail P [0000-0003-3089-4028], Gronberg, Henrik [0000-0002-1073-2753], Eklund, Martin [0000-0001-5032-5266], Nordström, Tobias [0000-0003-4915-7546], Pashayan, Nora [0000-0003-0843-2468], Dunning, Alison M [0000-0001-6651-7166], Travis, Ruth C [0000-0002-9571-0763], Riboli, Elio [0000-0001-6795-6080], Park, Jong Y [0000-0002-6384-6447], Weinstein, Stephanie J [0000-0002-3834-1535], Kraft, Peter [0000-0002-4472-8103], Ostrander, Elaine A [0000-0001-6075-9738], Wolk, Alicja [0000-0001-7387-6845], Håkansson, Niclas [0000-0001-7673-5554], Machiela, Mitchell J [0000-0001-6538-9705], Sørensen, Karina Dalsgaard [0000-0002-4902-5490], Zheng, Wei [0000-0003-1226-070X], Mensah, James E [0000-0003-4133-1722], Lu, Yong-Jie [0000-0001-6174-6621], West, Catharine ML [0000-0002-0839-3449], Cancel-Tassin, Géraldine [0000-0002-9583-6382], Truong, Thérèse [0000-0002-2943-6786], Vega, Ana [0000-0002-7416-5137], Gómez-Caamaño, Antonio [0000-0002-9773-4590], Fachal, Laura [0000-0002-7256-9752], Kerns, Sarah L [0000-0002-6503-0011], Ostrer, Harry [0000-0002-2209-5376], Teixeira, Manuel R [0000-0002-4896-5982], Brandão, Andreia [0000-0003-0938-1543], Cannon-Albright, Lisa [0000-0003-2602-3668], Multigner, Luc [0000-0003-3205-8568], Klein, Eric A [0000-0002-1783-0698], Murphy, Adam B [0000-0001-9977-3473], Michael, Agnieszka [0000-0002-7262-6227], Ost, Piet [0000-0002-2203-4848], Xu, Jianfeng [0000-0002-1343-8752], Teo, Soo-Hwang [0000-0002-0444-590X], Lessel, Davor [0000-0003-4496-244X], Kulis, Tomislav [0000-0002-0895-5691], Joniau, Steven [0000-0003-3195-9890], Bush, William S [0000-0002-9729-6519], Crawford, Dana C [0000-0002-6437-6248], Roobol, Monique J [0000-0001-6967-1708], Jenster, Guido [0000-0002-8658-2552], Van Den Eeden, Stephen K [0000-0002-5599-8387], Easton, Douglas F [0000-0003-2444-3247], Chanock, Stephen J [0000-0002-2324-3393], Wiklund, Fredrik [0000-0002-4623-0544], Eeles, Rosalind A [0000-0002-3698-6241], Haiman, Christopher A [0000-0002-0097-9971], and Apollo - University of Cambridge Repository
- Subjects
Male ,8Q24 ,Genome-wide association study ,Continental Population Groups/genetics ,VARIANTS ,Prostate cancer ,0302 clinical medicine ,Risk Factors ,Epidemiology ,IMPUTATION ,Odds Ratio ,Prostatic Neoplasms/diagnosis ,0303 health sciences ,education.field_of_study ,Continental Population Groups ,Manchester Cancer Research Centre ,Middle Aged ,Càncer--Aspectes genètics ,3. Good health ,ODDS RATIOS ,06 Biological Sciences, 11 Medical and Health Sciences ,medicine.medical_specialty ,Population ,Biology ,prostate cancer ,meta-analysis ,SEQUENCE ,Article ,03 medical and health sciences ,Breast cancer ,SDG 3 - Good Health and Well-being ,Genetics ,medicine ,BREAST-CANCER ,Humans ,Genetic Predisposition to Disease ,Neoplasm Invasiveness ,education ,030304 developmental biology ,Genetic association ,[SDV.GEN]Life Sciences [q-bio]/Genetics ,MUTATIONS ,ResearchInstitutes_Networks_Beacons/mcrc ,Racial Groups ,Prostatic Neoplasms ,Molecular Sequence Annotation ,Odds ratio ,medicine.disease ,BRCA2 ,Pròstata--Càncer ,Genetic Loci ,030217 neurology & neurosurgery ,Imputation (genetics) ,Genètica ,Demography ,Developmental Biology ,Genome-Wide Association Study - Abstract
International audience; Prostate cancer is a highly heritable disease with large disparities in incidence rates across ancestry populations. We conducted a multiancestry meta-analysis of prostate cancer genome-wide association studies (107,247 cases and 127,006 controls) and identified 86 new genetic risk variants independently associated with prostate cancer risk, bringing the total to 269 known risk variants. The top genetic risk score (GRS) decile was associated with odds ratios that ranged from 5.06 (95% confidence interval (CI), 4.84-5.29) for men of European ancestry to 3.74 (95% CI, 3.36-4.17) for men of African ancestry. Men of African ancestry were estimated to have a mean GRS that was 2.18-times higher (95% CI, 2.14-2.22), and men of East Asian ancestry 0.73-times lower (95% CI, 0.71-0.76), than men of European ancestry. These findings support the role of germline variation contributing to population differences in prostate cancer risk, with the GRS offering an approach for personalized risk prediction.
- Published
- 2021
- Full Text
- View/download PDF
44. Composition and interfacial properties play key roles in different lipid digestion between goat and cow milk fat globules in vitro
- Author
-
Xueying Mao, Lili Zhao, and Jun Wang
- Subjects
Phospholipid ,Pasteurization ,Homogenization (chemistry) ,Analytical Chemistry ,law.invention ,chemistry.chemical_compound ,law ,Animals ,Food science ,Globules of fat ,Glycoproteins ,Chemistry ,Goats ,food and beverages ,Lipid Droplets ,General Medicine ,Lipids ,In vitro ,Cattle ,Digestion ,Female ,lipids (amino acids, peptides, and proteins) ,Composition (visual arts) ,Glycolipids ,Lipid digestion ,Food Science - Abstract
The different TAG, interfacial properties and digestion rate between goat and cow milk fat globules were investigated. The mechanism of their different lipid digestion was also elucidated. Raw goat milk fat globules had smaller size, less large molecular weight and unsaturated TAG, larger liquid-ordered region and fewer glycoproteins, which contributed to the higher digestion rate than cow milk. After homogenization, the goat lipids also had higher digestion rate that was attributed to the special structure of easy-to-digest TAG and less glycosylated molecules not globule size. More integrated phospholipid layers and glycosylated molecules of HTST milk fat globules resulted in a lower lipid digestion rate than other processed milks. No difference in digestion rate between pasteurized goat and cow milk fat globules might be explained by the more denatured proteins and glycosylated molecules, respectively. Therefore, the TAG and interfacial properties contributed to different digestion between goat and cow milk fat globules.
- Published
- 2022
- Full Text
- View/download PDF
45. Dietary Milk Fat Globule Membrane Restores Decreased Intestinal Mucosal Barrier Development and Alterations of Intestinal Flora in Infant-Formula-Fed Rat Pups
- Author
-
Qichen Yuan, Han Gong, Biyuan Zhan, Xueying Mao, Jinzhu Pang, Jufang Li, Rui Chang, and Tiange Li
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Breast milk ,Body weight ,Rats, Sprague-Dawley ,03 medical and health sciences ,Internal medicine ,medicine ,Animals ,Humans ,Intestinal Mucosa ,Milk fat globule ,Glycoproteins ,030109 nutrition & dietetics ,Tight Junction Proteins ,Tight junction ,Chemistry ,Body Weight ,Infant ,Lipid Droplets ,Intestinal mucosal barrier ,Intestinal epithelium ,Infant Formula ,Gastrointestinal Microbiome ,Sprague dawley ,030104 developmental biology ,Endocrinology ,Infant formula ,Animals, Newborn ,Dietary Supplements ,Glycolipids ,Spleen ,Food Science ,Biotechnology - Abstract
Scope Milk fat globule membrane (MFGM), which contains abundant polar lipids and glycoproteins, can narrow the gap in growth and development between breast-fed and infant-formula-fed babies. The objective of this study is to evaluate the effect of MFGM supplementation in infant formula on intestinal epithelium maturation, tight junctions, and gut colonization in rat pups. Methods and results Sprague Dawley rat pups consume one of the five diets from postnatal day 8, including rat breastfeeding (BF), infant formula (IF), and infant formula containing MFGM at 260 mg kg-1 body weight (BW), 520 mg kg-1 BW, or 1040 mg kg-1 BW. Results show that MFGM supplementation in infant formula can facilitate intestinal mucosal barrier maturation via promoting intestinal proliferation and differentiation, and increasing tight junction proteins. In addition, compared with that of the IF pups, the intestinal flora composition of MFGM-supplemented pups is more similar to that of BF pups. Conclusion MFGM supplementation in infant formula can restore the intestinal development in infant-formula-fed pups, which suggests that the supplementation of MFGM in infant formula can better mimic breast milk.
- Published
- 2020
46. Water Extract of Potentilla discolor Bunge Improves Hepatic Glucose Homeostasis by Regulating Gluconeogenesis and Glycogen Synthesis in High-Fat Diet and Streptozotocin-Induced Type 2 Diabetic Mice
- Author
-
Rui Chang, Xueying Mao, Tiange Li, Min Du, and Huijuan Zhang
- Subjects
0301 basic medicine ,medicine.medical_specialty ,medicine.medical_treatment ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,lcsh:TX341-641 ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,medicine ,insulin sensitivity ,Glycogen synthase ,Protein kinase A ,Protein kinase B ,030109 nutrition & dietetics ,Nutrition and Dietetics ,biology ,Glycogen ,Chemistry ,Insulin ,Streptozotocin ,glycogen synthesis ,Endocrinology ,gluconeogenesis ,Gluconeogenesis ,biology.protein ,Potentilla discolor Bunge ,type 2 diabetes ,Phosphoenolpyruvate carboxykinase ,lcsh:Nutrition. Foods and food supply ,medicine.drug ,Food Science - Abstract
Potentilla discolor Bunge, as a traditional Chinese medicine, exhibits many phytochemical activities. The aim of the present study was to investigate the effects of Potentilla discolor Bunge water extract (PDBW) and its underlying mechanisms on gluconeogenesis and glycogen synthesis in high-fat diet/streptozotocin (HFD/STZ)-induced type 2 diabetic mice. LC-MS/MS analyses of PDBW identified 6 major compounds including apigenin-7-O-β-D-glucoside, epicatechin, quercetin 3-O-β-D-glucuronide, kaempferol-3-O-β-D-glucopyranoside, scutellarin, and quercitrin. In the study, a mouse model of type 2 diabetes was induced by 4-week HFD combined with STZ (40 mg/kg body weight) for 5 days. After oral administration of PDBW at 400 mg/kg body weight daily for 8 weeks, the mice with type 2 diabetes showed significant decrease in the levels of fasting blood glucose and glycated hemoglobin A1c (HbA1c), and increase in the insulin level. PDBW improved the glucose tolerance, insulin sensitivity and lipid profiles. Furthermore, PDBW inhibited the mRNA levels of key gluconeogenic enzymes [phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase)] in liver. PDBW also promoted glycogen synthesis by raising the liver glycogen content, decreasing the phosphorylation of glycogen synthase (GS) and increasing the phosphorylation of glycogen synthase kinase3β (GSK3β). Besides, PDBW induced the activation of protein kinase B (Akt) and AMP-activated protein kinase (AMPK), which might explain changes in the phosphorylation of above enzymes. In summary, PDBW supplementation ameliorates metabolic disorders in a HFD/STZ diabetic mouse model, suggesting the potential application of PDBW in prevention and amelioration of type 2 diabetes.
- Published
- 2020
- Full Text
- View/download PDF
47. Water Extract of
- Author
-
Tiange, Li, Rui, Chang, Huijuan, Zhang, Min, Du, and Xueying, Mao
- Subjects
gluconeogenesis ,insulin sensitivity ,Potentilla discolor Bunge ,type 2 diabetes ,Nutrition ,Original Research ,glycogen synthesis - Abstract
Potentilla discolor Bunge, as a traditional Chinese medicine, exhibits many phytochemical activities. The aim of the present study was to investigate the effects of Potentilla discolor Bunge water extract (PDBW) and its underlying mechanisms on gluconeogenesis and glycogen synthesis in high-fat diet/streptozotocin (HFD/STZ)-induced type 2 diabetic mice. LC-MS/MS analyses of PDBW identified 6 major compounds including apigenin-7-O-β-D-glucoside, epicatechin, quercetin 3-O-β-D-glucuronide, kaempferol-3-O-β-D-glucopyranoside, scutellarin, and quercitrin. In the study, a mouse model of type 2 diabetes was induced by 4-week HFD combined with STZ (40 mg/kg body weight) for 5 days. After oral administration of PDBW at 400 mg/kg body weight daily for 8 weeks, the mice with type 2 diabetes showed significant decrease in the levels of fasting blood glucose and glycated hemoglobin A1c (HbA1c), and increase in the insulin level. PDBW improved the glucose tolerance, insulin sensitivity and lipid profiles. Furthermore, PDBW inhibited the mRNA levels of key gluconeogenic enzymes [phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase)] in liver. PDBW also promoted glycogen synthesis by raising the liver glycogen content, decreasing the phosphorylation of glycogen synthase (GS) and increasing the phosphorylation of glycogen synthase kinase3β (GSK3β). Besides, PDBW induced the activation of protein kinase B (Akt) and AMP-activated protein kinase (AMPK), which might explain changes in the phosphorylation of above enzymes. In summary, PDBW supplementation ameliorates metabolic disorders in a HFD/STZ diabetic mouse model, suggesting the potential application of PDBW in prevention and amelioration of type 2 diabetes.
- Published
- 2020
48. Dipeptidyl Peptidase-IV Inhibitory Activity and Related Molecular Mechanism of Bovine α-Lactalbumin-Derived Peptides
- Author
-
Han Gong, Jing Gao, and Xueying Mao
- Subjects
animal structures ,030309 nutrition & dietetics ,Dipeptidyl Peptidase 4 ,Size-exclusion chromatography ,Pharmaceutical Science ,030209 endocrinology & metabolism ,Inhibitory postsynaptic potential ,Tandem mass spectrometry ,Hydrolysate ,Dipeptidyl peptidase ,Article ,Analytical Chemistry ,lcsh:QD241-441 ,03 medical and health sciences ,Hydrolysis ,dipeptidyl peptidase-IV inhibition ,0302 clinical medicine ,lcsh:Organic chemistry ,Drug Discovery ,Animals ,Physical and Theoretical Chemistry ,chemistry.chemical_classification ,Lactalbumin ,0303 health sciences ,Dipeptidyl-Peptidase IV Inhibitors ,Chemistry ,bovine α-lactalbumin hydrolysate ,Organic Chemistry ,molecular docking ,Peptide Fragments ,Amino acid ,Biochemistry ,Chemistry (miscellaneous) ,bioactive peptide ,Molecular Medicine ,Cattle - Abstract
Identifying DPP-IV inhibitory peptides from dietary protein has attracted increased attention. In the present study, bovine &alpha, lactalbumin hydrolysates were generated by alcalase for various hydrolysis times, and DPP-IV inhibitory activity of these hydrolysates was determined. The 4 h hydrolysates displayed the most potent DPP-IV inhibitory activity, with DPP-IV inhibition rate of 82.30 ±, 1.39% at concentration of 1.0 mg/mL. DPP-IV inhibitory peptides were isolated from the 4 h-hydrolysates with gel filtration chromatography and reversed-phase high-performance liquid chromatography (RP-HPLC). Using liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI MS/MS), two DPP-IV inhibitory peptides were identified, and their amino acid sequences were Glu-Leu-Lys-Asp-Leu-Lys-Gly-Tyr (ELKDLKGY) and Ile-Leu-Asp-Lys-Val-Gly-Ile-Asn-Tyr (ILDKVGINY), respectively. Furthermore, molecular docking analysis showed that peptides ELKDLKGY and ILDKVGINY could form hydrogen bonds, pi-cation interactions, and salt bridges with DPP-IV. These findings indicated that bovine &alpha, lactalbumin may be a potential source of natural DPP-IV inhibitor.
- Published
- 2020
49. Antidiabetic Effect of Casein Glycomacropeptide Hydrolysates on High-Fat Diet and STZ-Induced Diabetic Mice via Regulating Insulin Signaling in Skeletal Muscle and Modulating Gut Microbiota
- Author
-
Xueying Mao, Qichen Yuan, Min Du, Biyuan Zhan, and Rui Chang
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,medicine.medical_treatment ,lcsh:TX341-641 ,Diet, High-Fat ,Article ,Diabetes Mellitus, Experimental ,insulin signaling pathway ,Mice ,03 medical and health sciences ,Increased muscle glycogen content ,Internal medicine ,medicine ,Animals ,casein glycomacropeptide hydrolysate ,skeletal muscle ,Glycogen synthase ,GSK3B ,Protein kinase B ,Glucose Transporter Type 4 ,030109 nutrition & dietetics ,Nutrition and Dietetics ,biology ,diabetes ,gut microbiota ,Chemistry ,Insulin ,Caseins ,Skeletal muscle ,Peptide Fragments ,Gastrointestinal Microbiome ,Insulin receptor ,030104 developmental biology ,medicine.anatomical_structure ,Endocrinology ,Diabetes Mellitus, Type 2 ,Gene Expression Regulation ,inflammation ,Dietary Supplements ,biology.protein ,lcsh:Nutrition. Foods and food supply ,GLUT4 ,Food Science - Abstract
This study evaluated the effects and the underlying mechanisms of casein glycomacropeptide hydrolysate (GHP) on high-fat diet-fed and streptozotocin-induced type 2 diabetes (T2D) in C57BL/6J mice. Results showed that 8-week GHP supplementation significantly decreased fasting blood glucose levels, restored insulin production, improved glucose tolerance and insulin tolerance, and alleviated dyslipidemia in T2D mice. In addition, GHP supplementation reduced the concentration of lipopolysaccharides (LPSs) and pro-inflammatory cytokines in serum, which led to reduced systematic inflammation. Furthermore, GHP supplementation increased muscle glycogen content in diabetic mice, which was probably due to the regulation of glycogen synthase kinase 3 beta and glycogen synthase. GHP regulated the insulin receptor substrate-1/phosphatidylinositol 3-kinase/protein kinase B pathway in skeletal muscle, which promoted glucose transporter 4 (GLUT4) translocation. Moreover, GHP modulated the overall structure and diversity of gut microbiota in T2D mice. GHP increased the Bacteroidetes/Firmicutes ratio and the abundance of S24-7, Ruminiclostridium, Blautia and Allobaculum, which might contribute to its antidiabetic effect. Taken together, our findings demonstrate that the antidiabetic effect of GHP may be associated with the recovery of skeletal muscle insulin sensitivity and the regulation of gut microbiota.
- Published
- 2020
- Full Text
- View/download PDF
50. Addition of buttermilk powder improved the rheological and storage properties of low-fat yogurt
- Author
-
Ran Feng, Xueying Mao, and Lili Zhao
- Subjects
low‐fat yogurt ,Buttermilk powder ,Chemistry ,Nutrition. Foods and food supply ,food and beverages ,buttermilk ,Dynamic mechanical analysis ,storage properties ,Protein content ,Viscosity ,rheological properties ,Rheology ,Fermentation ,TX341-641 ,Food science ,Food Science ,Original Research - Abstract
Buttermilk is used widely in dairy products due to its good emulsifying and nutritional properties. In the present study, 0%–4.0% (w/w) buttermilk powder was added to low‐fat yogurt with a constant protein content to investigate its efficacy on the rheological and storage properties of low‐fat yogurt. Buttermilk increased the final titration acidity. Addition of buttermilk decreased the pH at the gelation point, shortened the gelation time, and thus shortened the fermentation period. Storage modulus G', yield stress, yield strain, and compact cross‐links of the microstructure were enhanced greatly with addition of 1.0%‐2.0% (w/w) buttermilk powder. In addition, addition of buttermilk decreased whey separation and increased the viscosity and firmness of low‐fat yogurt during storage. Our findings suggest that the addition of an appropriate amount of buttermilk altered the rheological characteristics and improved the textural and storage properties of low‐fat yogurt., In present study, 0%–4.0% (w/w) buttermilk powder was added to low‐fat yogurt with a constant protein content to investigate its efficacy on the rheological and storage properties of low‐fat yogurt. Addition of 1.0%‐2.0% (w/w) buttermilk powder could accelerate the fermentation period, decrease whey separation, and improve rheological, textural, and storage properties.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.